
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Fasting, ketogenic, and anti-inflammatory diets in multiple sclerosis: a randomized controlled trial with 18-month follow-up - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="D2E4B1498AF349B305B1490010A37D8F.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="bmcnutrition">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12366206/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="BMC Nutrition">
<meta name="citation_title" content="Fasting, ketogenic, and anti-inflammatory diets in multiple sclerosis: a randomized controlled trial with 18-month follow-up">
<meta name="citation_author" content="Lina S Bahr">
<meta name="citation_author_institution" content="Experimental and Clinical Research Center (ECRC), Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Lindenberger Weg 80, 13125 Berlin, Germany">
<meta name="citation_author_institution" content="Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany">
<meta name="citation_author_institution" content="Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité - Universitätsmedizin Berlin, Chariteplatz 1, 10117 Berlin, Germany">
<meta name="citation_author" content="Judith Bellmann-Strobl">
<meta name="citation_author_institution" content="Experimental and Clinical Research Center (ECRC), Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Lindenberger Weg 80, 13125 Berlin, Germany">
<meta name="citation_author_institution" content="Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany">
<meta name="citation_author_institution" content="Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité - Universitätsmedizin Berlin, Chariteplatz 1, 10117 Berlin, Germany">
<meta name="citation_author_institution" content="Neuroscience Clinical Research Center, Charité – Universitätsmedizin Berlin, Berlin, Germany">
<meta name="citation_author" content="Daniela A Koppold">
<meta name="citation_author_institution" content="Institute of Social Medicine, Epidemiology, and Health Economics, corporate member of Freie Universität Berlin and Humboldt-Universität, Charité - Universitätsmedizin, Berlin, Germany">
<meta name="citation_author_institution" content="Department of Internal Medicine and Nature-based Therapies, Immanuel Hospital Berlin, Berlin, Germany">
<meta name="citation_author_institution" content="Department of Pediatrics, Division of Oncology and Hematology, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Berlin, Germany">
<meta name="citation_author_institution" content="Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Berlin, Germany">
<meta name="citation_author" content="Rebekka Rust">
<meta name="citation_author_institution" content="Experimental and Clinical Research Center (ECRC), Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Lindenberger Weg 80, 13125 Berlin, Germany">
<meta name="citation_author_institution" content="Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany">
<meta name="citation_author_institution" content="Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité - Universitätsmedizin Berlin, Chariteplatz 1, 10117 Berlin, Germany">
<meta name="citation_author_institution" content="Institut für Med. Immunologie, Immundefektambulanz, Charité – Universitätsmedizin Berlin, Campus Virchow-Klinikum (CVK), Augustenburger Platz 1, 13353 Berlin, Germany">
<meta name="citation_author_institution" content="Neuroscience Clinical Research Center, Charité – Universitätsmedizin Berlin, Berlin, Germany">
<meta name="citation_author" content="Tanja Schmitz-Hübsch">
<meta name="citation_author_institution" content="Experimental and Clinical Research Center (ECRC), Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Lindenberger Weg 80, 13125 Berlin, Germany">
<meta name="citation_author_institution" content="Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany">
<meta name="citation_author_institution" content="Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité - Universitätsmedizin Berlin, Chariteplatz 1, 10117 Berlin, Germany">
<meta name="citation_author_institution" content="Neuroscience Clinical Research Center, Charité – Universitätsmedizin Berlin, Berlin, Germany">
<meta name="citation_author" content="Maja Olszewska">
<meta name="citation_author_institution" content="Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Berlin, Germany">
<meta name="citation_author" content="Jean Stadlbauer">
<meta name="citation_author_institution" content="Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Berlin, Germany">
<meta name="citation_author" content="Markus Bock">
<meta name="citation_author_institution" content="Department of Hand Surgery, Upper Extremity and Foot Surgery, Center for Orthopedic Rheumatology and Trauma Surgery, Hospital Waldfriede, Argentinische Allee 40, 14163 Berlin, Germany">
<meta name="citation_author_institution" content="Department of Endocrinology and Metabolic Diseases, Charité - Universitätsmedizin Berlin, Berlin, Germany">
<meta name="citation_author" content="Michael Scheel">
<meta name="citation_author_institution" content="Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Berlin, Germany">
<meta name="citation_author" content="Claudia Chien">
<meta name="citation_author_institution" content="Experimental and Clinical Research Center (ECRC), Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Lindenberger Weg 80, 13125 Berlin, Germany">
<meta name="citation_author_institution" content="Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany">
<meta name="citation_author_institution" content="Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité - Universitätsmedizin Berlin, Chariteplatz 1, 10117 Berlin, Germany">
<meta name="citation_author" content="Jan Multmeier">
<meta name="citation_author_institution" content="BioStats GmbH, Nauen, Germany">
<meta name="citation_author" content="Alexander Krannich">
<meta name="citation_author_institution" content="Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité - Universitätsmedizin Berlin, Chariteplatz 1, 10117 Berlin, Germany">
<meta name="citation_author_institution" content="BioStats GmbH, Nauen, Germany">
<meta name="citation_author" content="Andreas Michalsen">
<meta name="citation_author_institution" content="Institute of Social Medicine, Epidemiology, and Health Economics, corporate member of Freie Universität Berlin and Humboldt-Universität, Charité - Universitätsmedizin, Berlin, Germany">
<meta name="citation_author_institution" content="Department of Internal Medicine and Nature-based Therapies, Immanuel Hospital Berlin, Berlin, Germany">
<meta name="citation_author_institution" content="Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Berlin, Germany">
<meta name="citation_author" content="Friedemann Paul">
<meta name="citation_author_institution" content="Experimental and Clinical Research Center (ECRC), Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Lindenberger Weg 80, 13125 Berlin, Germany">
<meta name="citation_author_institution" content="Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany">
<meta name="citation_author_institution" content="Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité - Universitätsmedizin Berlin, Chariteplatz 1, 10117 Berlin, Germany">
<meta name="citation_author_institution" content="Neuroscience Clinical Research Center, Charité – Universitätsmedizin Berlin, Berlin, Germany">
<meta name="citation_author" content="Anja Mähler">
<meta name="citation_author_institution" content="Experimental and Clinical Research Center (ECRC), Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Lindenberger Weg 80, 13125 Berlin, Germany">
<meta name="citation_author_institution" content="Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany">
<meta name="citation_author_institution" content="Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité - Universitätsmedizin Berlin, Chariteplatz 1, 10117 Berlin, Germany">
<meta name="citation_publication_date" content="2025 Aug 20">
<meta name="citation_volume" content="11">
<meta name="citation_firstpage" content="167">
<meta name="citation_doi" content="10.1186/s40795-025-01156-5">
<meta name="citation_pmid" content="40836308">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12366206/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12366206/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12366206/pdf/40795_2025_Article_1156.pdf">
<meta name="description" content="Multiple sclerosis (MS) is the most common inflammatory disease of the central nervous system in young adulthood leading to disability and early retirement. Ketone-based diets improve the disease course in MS animal models and health outcomes in ...">
<meta name="og:title" content="Fasting, ketogenic, and anti-inflammatory diets in multiple sclerosis: a randomized controlled trial with 18-month follow-up">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Multiple sclerosis (MS) is the most common inflammatory disease of the central nervous system in young adulthood leading to disability and early retirement. Ketone-based diets improve the disease course in MS animal models and health outcomes in ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12366206/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12366206">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1186/s40795-025-01156-5"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/40795_2025_Article_1156.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12366206%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12366206/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12366206/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12366206/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-bmcnutrition.png" alt="BMC Nutrition logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to BMC Nutrition" title="Link to BMC Nutrition" shape="default" href="https://bmcnutr.biomedcentral.com/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">BMC Nutr</button></div>. 2025 Aug 20;11:167. doi: <a href="https://doi.org/10.1186/s40795-025-01156-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1186/s40795-025-01156-5</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22BMC%20Nutr%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22BMC%20Nutr%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22BMC%20Nutr%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22BMC%20Nutr%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Fasting, ketogenic, and anti-inflammatory diets in multiple sclerosis: a randomized controlled trial with 18-month follow-up</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bahr%20LS%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Lina S Bahr</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Lina S Bahr</span></h3>
<div class="p">
<sup>1</sup>Experimental and Clinical Research Center (ECRC), Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Lindenberger Weg 80, 13125 Berlin, Germany </div>
<div class="p">
<sup>3</sup>Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany </div>
<div class="p">
<sup>4</sup>Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité - Universitätsmedizin Berlin, Chariteplatz 1, 10117 Berlin, Germany </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bahr%20LS%22%5BAuthor%5D" class="usa-link"><span class="name western">Lina S Bahr</span></a>
</div>
</div>
<sup>1,</sup><sup>3,</sup><sup>4,</sup><sup>✉,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bellmann-Strobl%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Judith Bellmann-Strobl</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Judith Bellmann-Strobl</span></h3>
<div class="p">
<sup>1</sup>Experimental and Clinical Research Center (ECRC), Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Lindenberger Weg 80, 13125 Berlin, Germany </div>
<div class="p">
<sup>3</sup>Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany </div>
<div class="p">
<sup>4</sup>Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité - Universitätsmedizin Berlin, Chariteplatz 1, 10117 Berlin, Germany </div>
<div class="p">
<sup>11</sup>Neuroscience Clinical Research Center, Charité – Universitätsmedizin Berlin, Berlin, Germany </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bellmann-Strobl%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Judith Bellmann-Strobl</span></a>
</div>
</div>
<sup>1,</sup><sup>3,</sup><sup>4,</sup><sup>11,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Koppold%20DA%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Daniela A Koppold</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Daniela A Koppold</span></h3>
<div class="p">
<sup>2</sup>Institute of Social Medicine, Epidemiology, and Health Economics, corporate member of Freie Universität Berlin and Humboldt-Universität, Charité - Universitätsmedizin, Berlin, Germany </div>
<div class="p">
<sup>6</sup>Department of Internal Medicine and Nature-based Therapies, Immanuel Hospital Berlin, Berlin, Germany </div>
<div class="p">
<sup>7</sup>Department of Pediatrics, Division of Oncology and Hematology, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Berlin, Germany </div>
<div class="p">
<sup>12</sup>Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Berlin, Germany </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Koppold%20DA%22%5BAuthor%5D" class="usa-link"><span class="name western">Daniela A Koppold</span></a>
</div>
</div>
<sup>2,</sup><sup>6,</sup><sup>7,</sup><sup>12</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rust%20R%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Rebekka Rust</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Rebekka Rust</span></h3>
<div class="p">
<sup>1</sup>Experimental and Clinical Research Center (ECRC), Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Lindenberger Weg 80, 13125 Berlin, Germany </div>
<div class="p">
<sup>3</sup>Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany </div>
<div class="p">
<sup>4</sup>Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité - Universitätsmedizin Berlin, Chariteplatz 1, 10117 Berlin, Germany </div>
<div class="p">
<sup>8</sup>Institut für Med. Immunologie, Immundefektambulanz, Charité – Universitätsmedizin Berlin, Campus Virchow-Klinikum (CVK), Augustenburger Platz 1, 13353 Berlin, Germany </div>
<div class="p">
<sup>11</sup>Neuroscience Clinical Research Center, Charité – Universitätsmedizin Berlin, Berlin, Germany </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rust%20R%22%5BAuthor%5D" class="usa-link"><span class="name western">Rebekka Rust</span></a>
</div>
</div>
<sup>1,</sup><sup>3,</sup><sup>4,</sup><sup>8,</sup><sup>11</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Schmitz-H%C3%BCbsch%20T%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Tanja Schmitz-Hübsch</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Tanja Schmitz-Hübsch</span></h3>
<div class="p">
<sup>1</sup>Experimental and Clinical Research Center (ECRC), Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Lindenberger Weg 80, 13125 Berlin, Germany </div>
<div class="p">
<sup>3</sup>Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany </div>
<div class="p">
<sup>4</sup>Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité - Universitätsmedizin Berlin, Chariteplatz 1, 10117 Berlin, Germany </div>
<div class="p">
<sup>11</sup>Neuroscience Clinical Research Center, Charité – Universitätsmedizin Berlin, Berlin, Germany </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Schmitz-H%C3%BCbsch%20T%22%5BAuthor%5D" class="usa-link"><span class="name western">Tanja Schmitz-Hübsch</span></a>
</div>
</div>
<sup>1,</sup><sup>3,</sup><sup>4,</sup><sup>11</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Olszewska%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Maja Olszewska</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Maja Olszewska</span></h3>
<div class="p">
<sup>12</sup>Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Berlin, Germany </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Olszewska%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Maja Olszewska</span></a>
</div>
</div>
<sup>12</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Stadlbauer%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Jean Stadlbauer</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Jean Stadlbauer</span></h3>
<div class="p">
<sup>12</sup>Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Berlin, Germany </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Stadlbauer%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jean Stadlbauer</span></a>
</div>
</div>
<sup>12</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bock%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Markus Bock</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Markus Bock</span></h3>
<div class="p">
<sup>9</sup>Department of Hand Surgery, Upper Extremity and Foot Surgery, Center for Orthopedic Rheumatology and Trauma Surgery, Hospital Waldfriede, Argentinische Allee 40, 14163 Berlin, Germany </div>
<div class="p">
<sup>10</sup>Department of Endocrinology and Metabolic Diseases, Charité - Universitätsmedizin Berlin, Berlin, Germany </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bock%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Markus Bock</span></a>
</div>
</div>
<sup>9,</sup><sup>10</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Scheel%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Michael Scheel</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Michael Scheel</span></h3>
<div class="p">
<sup>12</sup>Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Berlin, Germany </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Scheel%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Michael Scheel</span></a>
</div>
</div>
<sup>12</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chien%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Claudia Chien</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Claudia Chien</span></h3>
<div class="p">
<sup>1</sup>Experimental and Clinical Research Center (ECRC), Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Lindenberger Weg 80, 13125 Berlin, Germany </div>
<div class="p">
<sup>3</sup>Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany </div>
<div class="p">
<sup>4</sup>Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité - Universitätsmedizin Berlin, Chariteplatz 1, 10117 Berlin, Germany </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chien%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Claudia Chien</span></a>
</div>
</div>
<sup>1,</sup><sup>3,</sup><sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Multmeier%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Jan Multmeier</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Jan Multmeier</span></h3>
<div class="p">
<sup>5</sup>BioStats GmbH, Nauen, Germany </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Multmeier%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jan Multmeier</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Krannich%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">Alexander Krannich</span></a><div hidden="hidden" id="id12">
<h3><span class="name western">Alexander Krannich</span></h3>
<div class="p">
<sup>4</sup>Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité - Universitätsmedizin Berlin, Chariteplatz 1, 10117 Berlin, Germany </div>
<div class="p">
<sup>5</sup>BioStats GmbH, Nauen, Germany </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Krannich%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Alexander Krannich</span></a>
</div>
</div>
<sup>4,</sup><sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Michalsen%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id13"><span class="name western">Andreas Michalsen</span></a><div hidden="hidden" id="id13">
<h3><span class="name western">Andreas Michalsen</span></h3>
<div class="p">
<sup>2</sup>Institute of Social Medicine, Epidemiology, and Health Economics, corporate member of Freie Universität Berlin and Humboldt-Universität, Charité - Universitätsmedizin, Berlin, Germany </div>
<div class="p">
<sup>6</sup>Department of Internal Medicine and Nature-based Therapies, Immanuel Hospital Berlin, Berlin, Germany </div>
<div class="p">
<sup>12</sup>Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Berlin, Germany </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Michalsen%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Andreas Michalsen</span></a>
</div>
</div>
<sup>2,</sup><sup>6,</sup><sup>12,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Paul%20F%22%5BAuthor%5D" class="usa-link" aria-describedby="id14"><span class="name western">Friedemann Paul</span></a><div hidden="hidden" id="id14">
<h3><span class="name western">Friedemann Paul</span></h3>
<div class="p">
<sup>1</sup>Experimental and Clinical Research Center (ECRC), Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Lindenberger Weg 80, 13125 Berlin, Germany </div>
<div class="p">
<sup>3</sup>Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany </div>
<div class="p">
<sup>4</sup>Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité - Universitätsmedizin Berlin, Chariteplatz 1, 10117 Berlin, Germany </div>
<div class="p">
<sup>11</sup>Neuroscience Clinical Research Center, Charité – Universitätsmedizin Berlin, Berlin, Germany </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Paul%20F%22%5BAuthor%5D" class="usa-link"><span class="name western">Friedemann Paul</span></a>
</div>
</div>
<sup>1,</sup><sup>3,</sup><sup>4,</sup><sup>11,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22M%C3%A4hler%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id15"><span class="name western">Anja Mähler</span></a><div hidden="hidden" id="id15">
<h3><span class="name western">Anja Mähler</span></h3>
<div class="p">
<sup>1</sup>Experimental and Clinical Research Center (ECRC), Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Lindenberger Weg 80, 13125 Berlin, Germany </div>
<div class="p">
<sup>3</sup>Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany </div>
<div class="p">
<sup>4</sup>Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité - Universitätsmedizin Berlin, Chariteplatz 1, 10117 Berlin, Germany </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22M%C3%A4hler%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Anja Mähler</span></a>
</div>
</div>
<sup>1,</sup><sup>3,</sup><sup>4,</sup><sup>#</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>Experimental and Clinical Research Center (ECRC), Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Lindenberger Weg 80, 13125 Berlin, Germany </div>
<div id="Aff2">
<sup>2</sup>Institute of Social Medicine, Epidemiology, and Health Economics, corporate member of Freie Universität Berlin and Humboldt-Universität, Charité - Universitätsmedizin, Berlin, Germany </div>
<div id="Aff3">
<sup>3</sup>Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany </div>
<div id="Aff4">
<sup>4</sup>Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité - Universitätsmedizin Berlin, Chariteplatz 1, 10117 Berlin, Germany </div>
<div id="Aff5">
<sup>5</sup>BioStats GmbH, Nauen, Germany </div>
<div id="Aff6">
<sup>6</sup>Department of Internal Medicine and Nature-based Therapies, Immanuel Hospital Berlin, Berlin, Germany </div>
<div id="Aff7">
<sup>7</sup>Department of Pediatrics, Division of Oncology and Hematology, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Berlin, Germany </div>
<div id="Aff8">
<sup>8</sup>Institut für Med. Immunologie, Immundefektambulanz, Charité – Universitätsmedizin Berlin, Campus Virchow-Klinikum (CVK), Augustenburger Platz 1, 13353 Berlin, Germany </div>
<div id="Aff9">
<sup>9</sup>Department of Hand Surgery, Upper Extremity and Foot Surgery, Center for Orthopedic Rheumatology and Trauma Surgery, Hospital Waldfriede, Argentinische Allee 40, 14163 Berlin, Germany </div>
<div id="Aff10">
<sup>10</sup>Department of Endocrinology and Metabolic Diseases, Charité - Universitätsmedizin Berlin, Berlin, Germany </div>
<div id="Aff11">
<sup>11</sup>Neuroscience Clinical Research Center, Charité – Universitätsmedizin Berlin, Berlin, Germany </div>
<div id="Aff12">
<sup>12</sup>Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Berlin, Germany </div>
<div class="author-notes p">
<div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div>
<div class="fn" id="_eqcntrb93pmc__">
<sup>#</sup><p class="display-inline">Contributed equally.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Feb 10; Accepted 2025 Aug 8; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12366206  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40836308/" class="usa-link">40836308</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<section id="sec1"><h3 class="pmc_sec_title">Background</h3>
<p id="Par1">Multiple sclerosis (MS) is the most common inflammatory disease of the central nervous system in young adulthood leading to disability and early retirement. Ketone-based diets improve the disease course in MS animal models and health outcomes in different pilot studies of neurodegenerative diseases.</p></section><section id="sec2"><h3 class="pmc_sec_title">Methods</h3>
<p id="Par2">We enrolled 105 individuals with relapsing-remitting MS (RRMS) in an 18-month, randomized, controlled study, and randomized them into (1) standard healthy diet (SD) as recommended by the German Nutrition Society, (2) fasting diet (FD) with 7-day fasts every 6 months with intermittent fasting at 6 of 7 days a week or (3) ketogenic diet (KD) with 20–40 g carbohydrates per day. Primary outcome was the number of new MRI lesions after 18 months in the KD and FD compared to SD and compared to baseline. Secondary outcomes included further MRI outcomes, disease biomarkers as well as metabolic, and clinical MS outcomes.</p></section><section id="sec3"><h3 class="pmc_sec_title">Results</h3>
<p id="Par3">Eighty-one participants completed the study. The primary endpoint number of new T2 lesions after 18 months did not change in any of the groups (SD 0 (0-(-1)), FD 0 (2 − 0), KD 0 (2 − 0)). Secondary endpoints were analyzed exploratorily: Compared to baseline, in the FD group, Neurofilament light chain (NfL) -concentrations were lower at 9 months (-1.94 pg/mL, <em>p</em> = 0.042) and depressive symptoms improved slightly at 18 months (<em>p</em> = 0.079). In the KD group, cognition improved at 18 months (symbol digit modalities test + 3.7, <em>p</em> = 0.020). Cardiometabolic risk markers (body mass index, abdominal fat, blood lipids, adipokines, blood pressure) improved in all three groups at 9 months differently and were partially associated with clinical outcomes in the FD and KD group.</p></section><section id="sec4"><h3 class="pmc_sec_title">Conclusion</h3>
<p id="Par4">The results suggest beneficial effects of dietary interventions, underscoring their potential as a complementary strategy in the treatment of RRMS. To further clarify the impact of such interventions on the disease course and patient-centered outcomes — such as cognitive function and depressive symptoms —future studies with larger, more homogeneous study populations are warranted.</p></section><section id="sec5"><h3 class="pmc_sec_title">Trial registration</h3>
<p id="Par5">ClinicalTrials.gov, <a href="https://clinicaltrials.gov/ct2/show/NCT03508414" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT03508414</a>. Retrospectively registered on 25 April 2018.</p></section><section id="sec6"><h3 class="pmc_sec_title">Supplementary Information</h3>
<p>The online version contains supplementary material available at 10.1186/s40795-025-01156-5.</p></section><section id="kwd-group1" lang="en" class="kwd-group"><p><strong>Keywords:</strong> Anti-inflammatory diet, Dietary intervention, Fasting, Caloric restriction, Ketogenic diet, Multiple sclerosis, NfL, Cognition, MRI, Cardiometabolic risk</p></section></section><section id="Sec1"><h2 class="pmc_sec_title">Introduction</h2>
<p id="Par29">Multiple sclerosis (MS) is an autoimmune inflammatory and neurodegenerative disorder of the central nervous system caused by a combination of genetic susceptibility and environmental factors [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>]. Many individuals with MS are highly motivated to incorporate complementary approaches, such as specific diets, into their treatment. However, despite 70 years of research efforts in this field, there is still no evidence-based diet showing a beneficial effect on disease progression. Current dietary recommendations, such as the Mediterranean diet, aim at decreasing the risk of comorbidities, and thereby secondarily ameliorate prognosis [<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>]. However, robust evidence of effects of healthy, anti-inflammatory diets on MS disease pathology itself is still lacking [<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>, <a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>].</p>
<p id="Par30">In contrast, emerging data on fasting diets (FD) and ketogenic diets (KD) indicate direct effects. Both FD and KD drastically reduce carbohydrate intake, initiating ketone body production from internal and/or external fats, the state of ketosis. These ketone bodies may provide an alternative, more efficient, energy source for the brain, which might be important for the regeneration of demyelinated axons [<a href="#CR5" class="usa-link" aria-describedby="CR5">5</a>].</p>
<p id="Par31">First indicators on the effectiveness of FDs in MS come from animal experimental studies. A calorie restriction of 40% ameliorated the clinical disease course of murine experimental autoimmune encephalomyelitis (EAE). Calorie restricted mice showed less severe inflammation, demyelination, and axonal injury [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>]. In addition, alternate day fasting in EAE mice reduced incidence, onset, and severity of the disease [<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>]. A similar study confirmed these results and suggested that intermittent fasting should be initiated shortly after disease onset [<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>].</p>
<p id="Par32">Fitzgerald et al. investigated safety, feasibility, weight loss and participant reported outcomes after 8 weeks of calorie restriction and intermittent fasting in individuals with MS. Both diets caused significant weight loss and increased emotional well-being [<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>].</p>
<p id="Par33">KDs seem to be equally promising. KD was established as an alternative treatment for pharmaco-resistant childhood epilepsy in the 1920s [<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>]. This was based on the observation that seizures stopped during fasting, but extended fasting periods in children were obviously not reasonable. Consequently, KD was developed to mimic biochemical effects caused by fasting [<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>]. KDs also seem to improve symptoms of neurodegenerative diseases, such as Alzheimer´s and Parkinson´s disease [<a href="#CR12" class="usa-link" aria-describedby="CR12">12</a>, <a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>]. EAE mice on KD showed ameliorated disease progression, motor disability, hippocampal atrophy, lesion load, inflammation, and oxidative stress [<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>]. In our own study we investigated feasibility, safety and health-related quality of life associated with a 6-month FD and KD intervention in individuals with relapsing-remitting MS (RRMS) [<a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>]. A single-arm, uncontrolled study reported improved metabolic and neurological outcomes after 6 months of a modified Atkins diet in individuals with RRMS [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>, <a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>].</p>
<p id="Par34">Based on this evidence, we designed a large-scale, long-term, randomized, controlled clinical study to investigate the effects of a FD and a KD compared to a standard healthy diet (SD) with anti-inflammatory focus in individuals with RRMS. We hypothesized that both FD and KD are superior to SD with respect to new cerebral lesions on cranial T2-weighted magnetic resonance imaging (MRI) after 18 months study interventions compared to baseline [<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>].</p></section><section id="Sec2"><h2 class="pmc_sec_title">Materials and methods</h2>
<section id="Sec92"><h3 class="pmc_sec_title">Study design and published work</h3>
<p id="Par35">The Nutritional Approaches in MS (NAMS) study was a single center, randomized, controlled, parallel group study (ClinicalTrials.gov, <a href="https://clinicaltrials.gov/ct2/show/NCT03508414" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT03508414</a>). Participants were randomized to either SD, FD, or KD. The study was conducted at the Neuroscience Clinical Research Center of Charité – Universitätsmedizin Berlin from April 2017 to October 2021 (last visit). Beside the study protocol [<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>], an interim analysis on the effects of the dietary interventions on neuropsychiatric symptoms was published in the scope of a doctoral thesis [<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>]. The study was conducted in part during the COVID-19 pandemic. To ensure transparent reporting of trial modifications, the CONSERVE extension of the CONSORT guidelines was applied. A completed CONSERVE checklist is provided in the supplement.</p>
<p id="Par36">In response to government-imposed travel restrictions, the study team, under the direction of the principal investigator, implemented protocol adjustments: between March 2020 and December 2021, dietary group sessions were temporarily conducted in a virtual format. To mitigate potential impacts on adherence, several measures were implemented. These, included enhancing opportunities for peer interaction during virtual group sessions and improving the accessibility of the study team -including dietary counselors and physicians – through increased availability via phone and online consultations.</p></section><section id="Sec93"><h3 class="pmc_sec_title">Participants</h3>
<p id="Par37">Main inclusion criteria were (1) definite diagnosis of RRMS according to the 2017 revised McDonald criteria [<a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>] and (2) stable disease modifying therapy (DMT) or no DMT for at least six months prior to enrolment, (3) recent disease activity had to be confirmed, defined as at least one new lesion on cranial MRI or at least one clinical relapse within the last two years prior to enrolment, (4) Expanded Disability Status Scale score (EDSS) had to be &lt; 4.5. Key exclusion criteria were start or change of DMT within six months before study start or during the study. The complete inclusion and exclusion criteria are listed in the published protocol [<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>]. The study was approved by the institutional review board of Charité – Universitätsmedizin Berlin (EA1/200/16). All research was performed in accordance with relevant guidelines/regulations and in accordance with the Declaration of Helsinki. Informed consent was obtained from all participants after screening to take part in the study and that pseudonymized data can be published. Recruitment efforts involved active outreach through medical practices and media engagement; however, these activities were partially limited by travel restrictions imposed during the pandemic.</p></section><section id="Sec94"><h3 class="pmc_sec_title">Randomization</h3>
<p id="Par38">Participants were stratified according to DMT use (yes or no), sex (male or female), and T2 lesion load (low (≤ 15) vs. high (&gt; 15)), to equally distribute potential confounder. Block randomization in treatment groups (1:1:1) was done by an external statistician, who was not involved in any study procedures. Whereas participants and study personnel could obviously not be blinded to the dietary intervention, outcome assessors (MRI, EDSS) were trained and blinded.</p></section><section id="Sec95"><h3 class="pmc_sec_title">Dietary interventions</h3>
<p id="Par39">Dietary interventions were instructed in 10 group sessions over 18 months. The group setting was chosen to encourage study adherence, explain dietary interventions, provide support, assess adverse events, and validly evaluate compliance. From March 2020 to December 2021, dietary groups sessions were conducted virtually, due to government-imposed travel restrictions. A detailed description of the interventions can be found in the study protocol [<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>].</p>
<p id="Par40">The SD group followed a healthy, mainly vegetarian-focused diet according to the recommendations of the German Society for Nutrition (DGE). Participants were additionally instructed to adapt their omega-6 to omega-3 fatty acid intake to reach a ratio of 5:1 to set an anti-inflammatory focus. Total energy intake was not restricted. Following intermittent fasting patterns and/or any other diets was prohibited, thereby ensuring discrimination between interventions. The SD group, functionally interpreted as our control group, received an intervention for recruitment and ethical reasons (an 18-months follow-up of participants not receiving any intervention would have been unethical and hardly feasible).</p>
<p id="Par41">The FD group fasted every 6 months for 7 days according to Buchinger [<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>]. Participants in this group attended additional group sessions every second day during the 7-day fasts. Between these fasts, participants practiced 14:10 time-restricted eating on 6 days each week. Dietary intake recommendations were the same as in the SD group.</p>
<p id="Par42">The KD group reduced their carbohydrate intake to 20–40 g/d and increased their fat intake to 70–80% of total energy intake. A focus on plant-based fats was advised. Participants were allowed to gradually increase their carbohydrate intake up to their individual limit (mostly at 40 g/d, maximum 50 g/d) to maintain stable ketosis, defined as ≥ 0.5 mmol/L blood beta-hydroxybutyrate (BHB). For self-monitoring, participants received a standard hand-held ketone-meter (GlucoMen LX plus). Ketone values were discussed and followed-up during study visits and dietary group sessions by the study team. The state of ketosis and measuring of blood ketones allowed to evaluate compliance according to a biomarker.</p></section><section id="Sec951"><h3 class="pmc_sec_title">Outcome parameters and assessment methods</h3>
<p id="Par43">The primary endpoint and all secondary endpoints were measured at baseline, after 9 and 18 months. A detailed list of all study assessments with assessment time points can be found in the study protocol SPIRIT flow diagram [<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>].</p>
<section id="Sec3"><h4 class="pmc_sec_title">Primary outcome</h4>
<p id="Par44">Primary outcome was the number of new T2-hyperintense lesions found in cranial MRI after 18 months on FD or KD compared to SD.</p></section><section id="Sec4"><h4 class="pmc_sec_title">Secondary outcomes</h4></section><section id="Sec5"><h4 class="pmc_sec_title">MRI outcomes and neurodegeneration markers</h4>
<p id="Par45">Brain atrophy was determined by percentage of brain volume change (PBVC) at 18 months vs. baseline. To increase internal validity of the primary endpoint, the secondary MRI endpoint change of lesion volume was amended during the study. Enlarged and/or aggregated lesions may result in unchanged or even reduced lesion counts but signify disease progression. By controlling for lesion volume, data analysis was adjusted for this potential systematic error. All MRI scans were done in a 3-Tesla MRI scanner (Tim Trio, Siemens, Erlangen, Germany) and lesions were segmented by two experienced and blinded MRI technicians.</p>
<p id="Par46">Serum neurofilament light chain (sNfL) was assessed retrospectively after completion of the study in the accredited laboratory (Labor Berlin, Charité Vivantes GmbH and Charité – Universitätsmedizin Berlin) according to standard procedures (Quanterix NFLight<sup>®</sup> Assay).</p></section><section id="Sec96"><h4 class="pmc_sec_title">Details on MRI acquisition and processing</h4>
<p id="Par47">Cerebral MRI scans were performed on two 3-Tesla (Siemens MAGNETOM Trio Tim and Prisma, Erlangen, Germany) scanner models, with 32-channel head coils. The Trio MRI (Scanner 1) protocol included: [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>] a T1-weighted 3D magnetization prepared rapid gradient echo (MPRAGE) cerebral MRI (1 mm isotropic resolution, repetition time (TR) = 1900ms, time to echo (TE) = 3.03ms, inversion time (TI) = 900ms); [<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>] a 3D T2-weighted fluid-attenuated inversion recovery sequence (FLAIR) (1 mm isotropic resolution, TR = 6000ms, TE = 388ms, TI = 1800ms). The Prisma MRI (Scanner 2) protocol included: [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>] a 3D MPRAGE (1 mm isotropic resolution, TR = 1900ms, TE = 3.03ms, TI = 900ms), including the upper cervical cord; [<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>] a 3D FLAIR (1 mm isotropic resolution, TR = 6000ms, TE = 390ms, TI = 2100ms). For each participant at each timepoint, FLAIR images were co-registered with MPRAGE images, in which each follow-up MPRAGE was co-registered to the baseline MPRAGE in Montreal Neurological Institute (MNI) space using FMRIB’s Linear Image Registration Tool (FSL version 5.0.9). Whole brain T2-weighted hyperintense lesion masks were manually segmented from co-registered FLAIR scans using ITK-SNAP (<a href="http://www.itksnap.org" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">www.itksnap.org</a>) by 2 MRI technicians (over 10 years of MS research experience). Lesion counts and volumes extraction were performed on binary lesion masks using cluster and fslstats tools (<a href="https://fsl.fmrib.ox.ac.uk/fsl/fslwiki/Fslutils" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://fsl.fmrib.ox.ac.uk/fsl/fslwiki/Fslutils</a>).</p></section><section id="Sec6"><h4 class="pmc_sec_title">Participant -centered outcomes</h4>
<section id="Sec97"><h5 class="pmc_sec_title">Functional and clinical outcomes</h5>
<p id="Par48">Hand grip strength was assessed with a standard hand dynamometer (Jamar smart hand [<a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>]) and walking endurance with the 6-min walk test (6MWT [<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>]), . Neurological–functional disability was assessed using the EDSS and the Multiple Sclerosis Functional Composite (MSFC [<a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>]). The MSFC evaluates multiples domains of functional impairment in individuals with MS, including gait speed (Timed 25-Foot Walk, T25FT), fine motor skills (9-Hole Peg Test, 9HPT) and cognitive function (Paced Auditory Serial Addition test, PASAT). The MSFC score was calculated based on z-scores and referenced against baseline values from the entire study population. Cognition (cognitive processing speed) was assessed with the oral Symbol Digit Modalities Test (SDMT [<a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>]), .</p>
<p id="Par49">Clinical relapses were assessed by the study physicians according to established criteria.</p></section><section id="Sec98"><h5 class="pmc_sec_title">Participant -reported outcomes</h5>
<p id="Par50">The presence of depressive symptoms was assessed with the Beck Depression Inventory-II (BDI-II [<a href="#CR26" class="usa-link" aria-describedby="CR26">26</a>]), , which is interpreted according to the following ranges: 0–8 (no depressive symptoms); 9–13 (minimal depressive symptoms); 14–19 (mild depressive symptoms); 20–28 (moderate depressive symptoms); 29–63 (severe depressive symptoms) [<a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>].</p>
<p id="Par51">Fatigue was assessed using the fatigue severity scale (FSS), with scores ≥ 4 indicating moderate-to-severe fatigue [<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>].</p>
<p id="Par52">Mental and physical health related quality of life were assessed with the MSQol-54, an established tool to assess MS-related quality of life. It includes 54 items that can be summed up to 12 multi-item scales (physical health, physical role limitations, emotional role limitations, pain, emotional well-being, energy, social function, cognitive function, health perception, health distress, overall quality of life, sexual function) and two single items (change in health, sexual function satisfaction). Two summary scores – physical health composite and mental health composite – can be derived from a weighted combination of scale scores [<a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>]. MSQoL-54 scale scores were created using the Likert method by averaging items within the scales, and then row scores were linearly transformed into 0-100 scales. Higher values indicate better quality of life.</p></section></section><section id="Sec99"><h4 class="pmc_sec_title">Cardiometabolic health, anthropometry and body composition</h4>
<p id="Par53">Blood glucose, BHB, insulin, adiponectin, leptin, total cholesterol, LDL cholesterol, HDL cholesterol and triglycerides were measured after a 12-h overnight fast in the accredited laboratory (Labor Berlin, Charité Vivantes GmbH and Charité – Universitätsmedizin Berlin) according to standard procedures. Metabolic markers were assessed in order to investigate their potential of mediating effects of dietary interventions. Potential mediators of dietary effects were assessed using the following parameters: body weight was measured with a standard scale (seca GmbH and Co.KG) and Body Mass Index (BMI) was calculated as weight divided by height squared (kg/m<sup>2</sup>). Blood pressure was recorded using automated oscillometric sphygmomanometry after a 5-minute seated rest. Body composition was evaluated via bioelectrical impedance analysis (Biacorpus RX 4000, MEDI CAL healthcare GmbH, Karlsruhe, Germany).</p></section><section id="Sec8"><h4 class="pmc_sec_title">Dietary intake</h4>
<p id="Par54">Macro- and micronutrient intake was calculated from food records, in which participants recorded the amounts of all consumed foods and drinks for four consecutive days (three week days and one weekend day), using the software OptiDiet PLUS 6.1 (GOE mbH, Linden, Germany) based on the German Nutrient Database.</p></section><section id="Sec9"><h4 class="pmc_sec_title">Safety of the diets and compliance</h4>
<p id="Par55">Safety was assessed by occurrence of (serious) adverse events, vital signs (blood pressure, heart rate), monitoring of body weight and markers for kidney (creatinine, uric acid, urea) and liver function (GPT, GOT, gamma-GT). Compliance for all participants was defined as attendance of at least 7 out of 10 group sessions over the study period. Food records at 0, 9 and 18 months allowed assessment of compliance with the different dietary recommendations. Compliance to the individual interventions was additionally defined as follows: SD, adherence to DGE recommendations; FD, attendance of dietary sessions during 7-day fasts; KD, 75% of study center assessed BHB concentrations ≥ 0.5 mmol/L.</p></section></section><section id="Sec100"><h3 class="pmc_sec_title">Data capture</h3>
<p id="Par56">Study data were collected and managed using REDCap electronic data capture tools hosted at Charité Berlin [<a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>, <a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>].</p></section><section id="Sec101"><h3 class="pmc_sec_title">Samples size calculation and data analysis</h3>
<p id="Par57">Sample size calculation and data management procedures are published in the protocol publication [<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>]. The primary endpoint was the number of new MRI lesions at 18 months assessed in the KD and FD group each in comparison to the SD group. Analysis of the primary endpoint was based on robust linear regression analysis in the ITT population, adjusted for baseline lesion load and lesion volume (to account for enlarged and/or aggregated lesions may result in unchanged or even reduced lesion counts but signify disease progression). In contrast to the initially planned ANCOVA analysis [<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>], the robust regression was preferred due to non-normally distributed data. Sensitivity analysis of the primary outcome was done applying robust linear regression in the PP population. Secondary endpoint analysis was based on linear regressions and Wilcoxon signed rank tests in the FAS population. Predictor analysis was performed post hoc. We have decided not to impute for missing values in the outcome parameters. All available cases were considered. Analysis was conducted with the software R version 4.3.1 (R Core Team (2023). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL <a href="https://www.R-project.org/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.R-project.org/</a>) [<a href="#CR32" class="usa-link" aria-describedby="CR32">32</a>] and IBM SPSS statistics version 26.</p></section></section><section id="Sec10"><h2 class="pmc_sec_title">Results</h2>
<p id="Par58">During the recruitment period, 981 potential participants contacted the study center, of which 130 participants suited for screening and 105 were included (Fig. <a href="#Fig1" class="usa-link">1</a>).</p>
<figure class="fig xbox font-sm" id="Fig1"><h3 class="obj_head">Fig. 1.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12366206_40795_2025_1156_Fig1_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea33/12366206/bd942bbc705b/40795_2025_1156_Fig1_HTML.jpg" loading="lazy" id="d33e765" height="688" width="708" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>CONSORT diagram of the NAMS study. In the SD group: two MRIs were not done, which is why two more cases had to be excluded from the full analysis set. DMT, disease modifying therapy</p></figcaption></figure><p id="Par60">Baseline characteristics are displayed in Table <a href="#Tab1" class="usa-link">1</a>. The a priori sample size of 111 participants was not reached, as the dropout rate was higher than the initially estimated 10%. Dropout rates were 21% in the SD, 14% in the FD, 28% in the KD group (Fig. <a href="#Fig1" class="usa-link">1</a>).</p>
<section class="tw xbox font-sm" id="Tab1"><h3 class="obj_head">Table 1.</h3>
<div class="caption p"><p>Baseline characteristics of the NAMS intention-to-treat population</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1"></th>
<th align="left" colspan="1" rowspan="1"></th>
<th align="left" colspan="1" rowspan="1">Total</th>
<th align="left" colspan="1" rowspan="1">SD</th>
<th align="left" colspan="1" rowspan="1">FD</th>
<th align="left" colspan="1" rowspan="1">KD</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Number of participants (n)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">105</td>
<td align="left" colspan="1" rowspan="1">34</td>
<td align="left" colspan="1" rowspan="1">35</td>
<td align="left" colspan="1" rowspan="1">36</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Age (years)</td>
<td align="left" colspan="1" rowspan="1">Mean (StD)</td>
<td align="left" colspan="1" rowspan="1">42 (9)</td>
<td align="left" colspan="1" rowspan="1">43 (10)</td>
<td align="left" colspan="1" rowspan="1">41 (9)</td>
<td align="left" colspan="1" rowspan="1">41 (10)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Ethnicity (Caucasian)</td>
<td align="left" colspan="1" rowspan="1">n (%)</td>
<td align="left" colspan="1" rowspan="1">100 (95)</td>
<td align="left" colspan="1" rowspan="1">34 (100)</td>
<td align="left" colspan="1" rowspan="1">34 (97)</td>
<td align="left" colspan="1" rowspan="1">32 (89)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Gender (female)</td>
<td align="left" colspan="1" rowspan="1">n (%)</td>
<td align="left" colspan="1" rowspan="1">88 (84)</td>
<td align="left" colspan="1" rowspan="1">29 (85)</td>
<td align="left" colspan="1" rowspan="1">28 (80)</td>
<td align="left" colspan="1" rowspan="1">31 (86)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Disease duration since manifestation (years)</td>
<td align="left" colspan="1" rowspan="1">Median (IQR)</td>
<td align="left" colspan="1" rowspan="1">8.0 (13.8–2.4)</td>
<td align="left" colspan="1" rowspan="1">5.0 (13.0-2.1)</td>
<td align="left" colspan="1" rowspan="1">8.9 (13.6–3.8)</td>
<td align="left" colspan="1" rowspan="1">8.6 (16.1-3.0)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Disease duration since diagnosis (years)</td>
<td align="left" colspan="1" rowspan="1">Median (IQR)</td>
<td align="left" colspan="1" rowspan="1">3.6 (10.3–1.3)</td>
<td align="left" colspan="1" rowspan="1">2.1 (5.4–1.2)</td>
<td align="left" colspan="1" rowspan="1">5.3 (11.1–2.1)</td>
<td align="left" colspan="1" rowspan="1">3.8 (10.6–1.3)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">EDSS score</td>
<td align="left" colspan="1" rowspan="1">
<p>Median</p>
<p>(IQR)</p>
</td>
<td align="left" colspan="1" rowspan="1">2.0 (2.5–1.5)</td>
<td align="left" colspan="1" rowspan="1">2.0 (2.5–1.5)</td>
<td align="left" colspan="1" rowspan="1">2.0 (2.1–1.5)</td>
<td align="left" colspan="1" rowspan="1">2.0 (3.1–1.5)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Number of T2-lesions</td>
<td align="left" colspan="1" rowspan="1">Median (IQR)</td>
<td align="left" colspan="1" rowspan="1">35 (75 − 19)</td>
<td align="left" colspan="1" rowspan="1">36 (76 − 21)</td>
<td align="left" colspan="1" rowspan="1">39 (67 − 23)</td>
<td align="left" colspan="1" rowspan="1">31 (76 − 17)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Participants with disease-modifying therapy</td>
<td align="left" colspan="1" rowspan="1">n (%)</td>
<td align="left" colspan="1" rowspan="1">60 (57)</td>
<td align="left" colspan="1" rowspan="1">20 (59)</td>
<td align="left" colspan="1" rowspan="1">19 (55)</td>
<td align="left" colspan="1" rowspan="1">21 (58)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em>Alemtuzumab</em>
</td>
<td align="left" rowspan="12" colspan="1">n (%)</td>
<td align="left" colspan="1" rowspan="1">1 (1)</td>
<td align="left" colspan="1" rowspan="1">1 (3)</td>
<td align="left" colspan="1" rowspan="1">0</td>
<td align="left" colspan="1" rowspan="1">0</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em>Cladribine</em>
</td>
<td align="left" colspan="1" rowspan="1">1 (1)</td>
<td align="left" colspan="1" rowspan="1">0</td>
<td align="left" colspan="1" rowspan="1">1 (3)</td>
<td align="left" colspan="1" rowspan="1">0</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em>Daclizumab</em>
</td>
<td align="left" colspan="1" rowspan="1">1 (1)</td>
<td align="left" colspan="1" rowspan="1">1 (3)</td>
<td align="left" colspan="1" rowspan="1">0</td>
<td align="left" colspan="1" rowspan="1">0</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em>Dimethyl fumarate</em>
</td>
<td align="left" colspan="1" rowspan="1">14 (13)</td>
<td align="left" colspan="1" rowspan="1">2 (6)</td>
<td align="left" colspan="1" rowspan="1">5 (14)</td>
<td align="left" colspan="1" rowspan="1">7 (19)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em>Fingolimod</em>
</td>
<td align="left" colspan="1" rowspan="1">10 (10)</td>
<td align="left" colspan="1" rowspan="1">2 (6)</td>
<td align="left" colspan="1" rowspan="1">5 (14)</td>
<td align="left" colspan="1" rowspan="1">3 (8)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em>Glatiramer acetate</em>
</td>
<td align="left" colspan="1" rowspan="1">15 (14)</td>
<td align="left" colspan="1" rowspan="1">8 (24)</td>
<td align="left" colspan="1" rowspan="1">3 (9)</td>
<td align="left" colspan="1" rowspan="1">4 (11)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em>Interferon beta-1a</em>
</td>
<td align="left" colspan="1" rowspan="1">7 (6)</td>
<td align="left" colspan="1" rowspan="1">0</td>
<td align="left" colspan="1" rowspan="1">3 (9)</td>
<td align="left" colspan="1" rowspan="1">4 (11)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em>Interferon beta-1b</em>
</td>
<td align="left" colspan="1" rowspan="1">3 (3)</td>
<td align="left" colspan="1" rowspan="1">1 (3)</td>
<td align="left" colspan="1" rowspan="1">0</td>
<td align="left" colspan="1" rowspan="1">2 (6)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em>Natalizumab</em>
</td>
<td align="left" colspan="1" rowspan="1">4 (4)</td>
<td align="left" colspan="1" rowspan="1">2 (6)</td>
<td align="left" colspan="1" rowspan="1">2 (6)</td>
<td align="left" colspan="1" rowspan="1">0</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em>Ocrelizumab</em>
</td>
<td align="left" colspan="1" rowspan="1">1 (1)</td>
<td align="left" colspan="1" rowspan="1">1 (3)</td>
<td align="left" colspan="1" rowspan="1">0</td>
<td align="left" colspan="1" rowspan="1">0</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em>Rituximab</em>
</td>
<td align="left" colspan="1" rowspan="1">2 (2)</td>
<td align="left" colspan="1" rowspan="1">1 (3)</td>
<td align="left" colspan="1" rowspan="1">0</td>
<td align="left" colspan="1" rowspan="1">1 (3)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<em>Teriflunomide</em>
</td>
<td align="left" colspan="1" rowspan="1">1 (1)</td>
<td align="left" colspan="1" rowspan="1">1 (3)</td>
<td align="left" colspan="1" rowspan="1">0</td>
<td align="left" colspan="1" rowspan="1">0</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Participants without disease-modifying therapy</td>
<td align="left" colspan="1" rowspan="1">n (%)</td>
<td align="left" colspan="1" rowspan="1">45 (43)</td>
<td align="left" colspan="1" rowspan="1">14 (41)</td>
<td align="left" colspan="1" rowspan="1">16 (46)</td>
<td align="left" colspan="1" rowspan="1">15 (42)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Body Mass Index (kg/m<sup>2</sup>)</td>
<td align="left" colspan="1" rowspan="1">Median (IQR)</td>
<td align="left" colspan="1" rowspan="1">24.3 (26.6–22.2)</td>
<td align="left" colspan="1" rowspan="1">25.1 (26.8–22.8)</td>
<td align="left" colspan="1" rowspan="1">23.6 (26.3–21.6)</td>
<td align="left" colspan="1" rowspan="1">23.7 (26.3–22.3)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">25-OH-Vitamin D3 (nmol/L)</td>
<td align="left" colspan="1" rowspan="1">Mean (StD)</td>
<td align="left" colspan="1" rowspan="1">101.0 (37.1)</td>
<td align="left" colspan="1" rowspan="1">105.1 (37.4)</td>
<td align="left" colspan="1" rowspan="1">93.9 (34.1)</td>
<td align="left" colspan="1" rowspan="1">104.2 (39.7)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Fatigue severity scale score</td>
<td align="left" colspan="1" rowspan="1">Median (IQR)</td>
<td align="left" colspan="1" rowspan="1">3.7 (5.3–2.2)</td>
<td align="left" colspan="1" rowspan="1">4.3 (5.6–1.8)</td>
<td align="left" colspan="1" rowspan="1">3.8 (5.2–2.8)</td>
<td align="left" colspan="1" rowspan="1">3.4 (4.4–2.2)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Beck depression inventory II score</td>
<td align="left" colspan="1" rowspan="1">Median (IQR)</td>
<td align="left" colspan="1" rowspan="1">7 (12 − 3)</td>
<td align="left" colspan="1" rowspan="1">7 (12 − 2)</td>
<td align="left" colspan="1" rowspan="1">9 (13 − 5)</td>
<td align="left" colspan="1" rowspan="1">6 (11 − 3)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Symbol digit modalities test score</td>
<td align="left" colspan="1" rowspan="1">Median (IQR)</td>
<td align="left" colspan="1" rowspan="1">56 (63 − 49)</td>
<td align="left" colspan="1" rowspan="1">54 (62 − 50)</td>
<td align="left" colspan="1" rowspan="1">57 (62 − 50)</td>
<td align="left" colspan="1" rowspan="1">57 (65 − 47)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p46"><p>EDSS, expanded disability status scale; FD, fasting diet; IQR, interquartile range; KD, ketogenic diet; SD, standard diet; StD, standard deviation, percentages of single DMTs have been rounded</p></div></div></section><p id="Par61">There were no relevant differences in age and sex between the groups. Disease duration of the SD group was shorter than of the KD and FD group. However, EDSS score, lesion load and percentage of participants on DMT was comparable between groups. The SD group showed lower cognition (SDMT) scores (age-adjusted cut-off ≤ 55 implies cognitive impairment) and higher fatigues (FSS) scores (cut-off ≥ 4 implies moderate fatigue), compared to KD and FD group.</p>
<section id="Sec11"><h3 class="pmc_sec_title">Primary outcome</h3>
<p id="Par63">Primary outcome analysis was applied in the ITT population. Treatment effects have been estimated from a robust linear regression with the number of new lesions as response, treatment group as fixed effect and adjusted for baseline number of T2-lesions and lesion volume. Treatment effects were estimated from Generalized Estimation Equations which show no difference between the groups regarding new number of T2 lesions at 18 months. Lesion volume influenced the number of new lesions at 18 months (Table <a href="#Tab2" class="usa-link">2</a>).</p>
<section class="tw xbox font-sm" id="Tab2"><h4 class="obj_head">Table 2.</h4>
<div class="caption p"><p>Robust linear regression for number of new lesions at 18 months (ITT population)</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Variable</th>
<th align="left" colspan="1" rowspan="1">Unstandardized B</th>
<th align="left" colspan="1" rowspan="1">Std. Error</th>
<th align="left" colspan="1" rowspan="1">z value</th>
<th align="left" colspan="1" rowspan="1">
<em>p</em>-value</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong>Primary analysis (ITT)</strong>
</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">KD (SD as reference)</td>
<td align="center" colspan="1" rowspan="1">0.305</td>
<td align="center" colspan="1" rowspan="1">1.205</td>
<td align="center" colspan="1" rowspan="1">0.253</td>
<td align="center" colspan="1" rowspan="1">0.801</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">FD (SD as reference)</td>
<td align="center" colspan="1" rowspan="1">0.809</td>
<td align="center" colspan="1" rowspan="1">1.171</td>
<td align="center" colspan="1" rowspan="1">0.691</td>
<td align="center" colspan="1" rowspan="1">0.492</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Lesion volume change (mm<sup>3</sup>)</td>
<td align="center" colspan="1" rowspan="1">-1.262</td>
<td align="center" colspan="1" rowspan="1">0.550</td>
<td align="center" colspan="1" rowspan="1">-2.297</td>
<td align="center" colspan="1" rowspan="1">0.024</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Baseline lesion load (n)</td>
<td align="center" colspan="1" rowspan="1">-0.003</td>
<td align="center" colspan="1" rowspan="1">0.011</td>
<td align="center" colspan="1" rowspan="1">-0.259</td>
<td align="center" colspan="1" rowspan="1">0.797</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="Sec102"><h3 class="pmc_sec_title">Sensitivity analysis</h3>
<p id="Par65">Sensitivity analysis investigated the per-protocol (PP) population and only emphasized significant predictive value for baseline lesion load (Table <a href="#Tab3" class="usa-link">3</a>). The number of new T2 lesions after 18 months vs. baseline did not change in any of the groups (primary endpoint; SD 0 (0-(-1)), FD 0 (2 − 0), KD 0 (2 − 0)) (Fig. <a href="#Fig2" class="usa-link">2</a>A). In line with this, lesion volume remained stable over 18 months in all three groups (Fig. <a href="#Fig2" class="usa-link">2</a>B).</p>
<section class="tw xbox font-sm" id="Tab3"><h4 class="obj_head">Table 3.</h4>
<div class="caption p"><p>Robust linear regression for number of new lesions at 18 months (PP population)</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Sensitivity analysis (PP)</th>
<th align="left" colspan="1" rowspan="1">Unstandardized B</th>
<th align="left" colspan="1" rowspan="1">Std. Error</th>
<th align="left" colspan="1" rowspan="1">z value</th>
<th align="left" colspan="1" rowspan="1">
<em>p</em>-value</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">KD (SD as reference)</td>
<td align="center" colspan="1" rowspan="1">0.055</td>
<td align="center" colspan="1" rowspan="1">0.344</td>
<td align="center" colspan="1" rowspan="1">0.160</td>
<td align="center" colspan="1" rowspan="1">0.873</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">FD (SD as reference)</td>
<td align="center" colspan="1" rowspan="1">0.065</td>
<td align="center" colspan="1" rowspan="1">0.298</td>
<td align="center" colspan="1" rowspan="1">0.217</td>
<td align="center" colspan="1" rowspan="1">0.829</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Lesion volume change (mm<sup>3</sup>)</td>
<td align="center" colspan="1" rowspan="1">-0.014</td>
<td align="center" colspan="1" rowspan="1">0.222</td>
<td align="center" colspan="1" rowspan="1">-0.065</td>
<td align="center" colspan="1" rowspan="1">0.948</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Baseline lesion load (n)</td>
<td align="center" colspan="1" rowspan="1">-0.011</td>
<td align="center" colspan="1" rowspan="1">0.003</td>
<td align="center" colspan="1" rowspan="1">-3.486</td>
<td align="center" colspan="1" rowspan="1">0.001</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p53"><p>FD, fasting diet; ITT, intention-to-treat; KD, ketogenic diet; SD, standard diet; PP, per protocol</p></div></div></section><figure class="fig xbox font-sm" id="Fig2"><h4 class="obj_head">Fig. 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12366206_40795_2025_1156_Fig2_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea33/12366206/4e8c2b97b36b/40795_2025_1156_Fig2_HTML.jpg" loading="lazy" id="d33e1434" height="474" width="708" alt="Fig. 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Imaging, and neurodegeneration markers in the standard diet (SD, black circles), fasting diet (FD, blue circles) and ketogenic diet (KD, red circles) of the NAMS study. (<strong>A</strong>) No change of the number of new MRI lesions (primary endpoint, ITT population). (<strong>B</strong>) No change of MRI lesion volume (ITT population). (<strong>C</strong>) Lower NfL concentrations at 9 months in the FD group (FAS population). <strong>A-B</strong>, data as median and interquartile range, <em>p</em> values by Wilcoxon signed-rank test. <strong>C</strong>, data as mean and standard deviation, <em>p</em> values by t-test</p></figcaption></figure><p id="Par67">In addition, while the use of DMT versus no use of DMT had no significant influence, female sex and changes of lesion volume were significant predictors of the number of new lesions at 18 months in the FAS population (data not shown). No influence of the dietary interventions was observed.</p></section><section id="Sec12"><h3 class="pmc_sec_title">Secondary outcomes</h3>
<p id="Par68">All secondary outcomes were analyzed in the FAS population unless explicitly mentioned otherwise.</p>
<section id="Sec13"><h4 class="pmc_sec_title">MRI outcomes and neurodegeneration markers</h4>
<p id="Par69">Percentage of brain volume change did not differ between the groups after 18 months study interventions (data not shown).</p>
<p id="Par70">Serum neurofilament light chain (NfL) decreased by -1.94 ((-0.80)-0.01) pg/mL at 9 months in the FD group (Fig. <a href="#Fig2" class="usa-link">2</a>C) but not 18 months compared to baseline. NfL concentrations at 18 months correlated positively with EDSS score (Spearman correlation, <em>r</em> = 0.370; <em>p</em> = 0.006) and MRI lesion count (Spearman correlation, <em>r</em> = 0.394; <em>p</em> = 0.003) in a pooled analysis of all groups.</p></section><section id="Sec14"><h4 class="pmc_sec_title">Participant-centered outcomes</h4>
<section id="Sec931"><h5 class="pmc_sec_title">Functional and clinical outcomes</h5>
<p id="Par72">Disability status assessed by hand grip strength, 6MWT, EDSS, MSFC remained stable over 18 months across all groups. SDMT scores remained stable in the SD group, showed a slight increase in the FD group, and increased in the KD group at 18 months (Fig. <a href="#Fig3" class="usa-link">3</a>A).</p>
<figure class="fig xbox font-sm" id="Fig3"><h6 class="obj_head">Fig. 3.</h6>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12366206_40795_2025_1156_Fig3_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea33/12366206/6b45b7d98bca/40795_2025_1156_Fig3_HTML.jpg" loading="lazy" id="d33e1499" height="201" width="669" alt="Fig. 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Patient-centered neuropsychiatric outcomes in the standard diet (SD, black circles), fasting diet (FD, blue circles) and ketogenic diet (KD, red circles) of the NAMS study (FAS population). (<strong>A</strong>) Improved cognition according to Symbol Digit Modalities Test (SDMT) at 18 months in the KD group. Data as mean and standard deviation, <em>p</em> value by t-test. (<strong>B</strong>) Slightly improved depressive symptoms according to Beck Depression Inventory (BDI-II) in the FD group. Data as median and interquartile range, <em>p</em> values by Wilcoxon signed-rank test</p></figcaption></figure><p id="Par73">Participants reported 29 clinical relapses during the study (SD, 7 (28%); FD, 9 (30%); KD, 13 (50%)). Differences were not significant according to Chi-square tests (KD vs. FD vs. SD, <em>p</em> = 0.184; KD vs. SD, <em>p</em> = 0.186; FD vs. SD, <em>p</em> = 1; KD vs. FD, <em>p</em> = 0.210).</p></section><section id="Sec932"><h5 class="pmc_sec_title">Participant-reported outcomes</h5>
<p id="Par74">BDI-II scores were slightly lower at 9 months (Unstandardized B = − 3.7, <em>p</em> = 0.065), and lower at 18 months (Unstandardized B = − 4.3, <em>p</em> = 0.015) in the FD vs. the SD group and improved over time in the FD group (Fig. <a href="#Fig3" class="usa-link">3</a>B). FSS scores remained stable over 18 months in all groups (Suppl. Tables <a href="#MOESM1" class="usa-link">3–5</a>). There was no relevant change in mental health and physical health related quality of life (Suppl. Tables <a href="#MOESM1" class="usa-link">3–5</a>).</p></section></section><section id="Sec15"><h4 class="pmc_sec_title">Cardiometabolic health, anthropometry and body composition</h4>
<p id="Par76">Changes of cardiometabolic risk markers were most prominent at 9 months. In the KD group, triglyceride concentrations were 14 [<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>] mg/dL lower at 9 months vs. baseline (Fig. <a href="#Fig4" class="usa-link">4</a>C). In the SD group, total cholesterol decreased by 12 [<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>] mg/dL (<em>p</em> = 0.017; Suppl. Tables <a href="#MOESM1" class="usa-link">3–5</a>)) and LDL cholesterol by 8 [<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>] mg/dL (<em>p</em> = 0.022) at 9 months vs. baseline (Fig. <a href="#Fig4" class="usa-link">4</a>D). In the FD group, LDL cholesterol decreased by a median of 8.5 (7.8–11.8) mg/dL (<em>p</em> = 0.049) comparing 9 months vs. baseline (Fig. <a href="#Fig4" class="usa-link">4</a>D). Leptin concentrations were lower (Unstandardized B = − 3.0, <em>p</em> = 0.017) and adiponectin concentrations were higher (Unstandardized B = 2.2, <em>p</em> = 0.039) in the KD vs. the SD group at 9 months, but not at 18 months. Leptin decreased in the FD group (baseline: 9 (15 − 4) µg/L, 9 months: 6 (13 − 4) µg/L; Suppl. Tables <a href="#MOESM1" class="usa-link">3–5</a>), however, not significant. In the KD group, Leptin decreased significantly by 3.5 (6.4) µg/L at 9 months (<em>p</em> = 0.044). Adiponectin significantly increased in the FD (+ 1.2 (2.3) µg/mL, <em>p</em> = 0.009) and with a trend in the KD group (+ 2.4 (5.4) µg/mL, <em>p</em> = 0.075). Insulin concentrations were lower at 9 months (Unstandardized B = − 1.7, <em>p</em> = 0.040) and 18 months (Unstandardized B = − 3.3, <em>p</em> = 0.001) in the FD group and at 18 months in the KD group (Unstandardized B = − 2.3, <em>p</em> = 0.058), each vs. the SD group (Suppl. Tables <a href="#MOESM1" class="usa-link">3–5</a>). Median weight losses at 9 months vs. baseline were 2.0 kg, 2.8 kg and 3.8 kg in the SD, FD, and KD group, respectively. Linear regression analysis showed that the KD (Unstandardized B = − 2.195, <em>p</em> = 0.039) and FD group (Unstandardized B = − 2.313, <em>p</em> = 0.022) had a lower body weight and BMI (KD, Unstandardized B = -0.9, <em>p</em> = 0.014) (FD, Unstandardized B = − 0.8, <em>p</em> = 0.015) compared to the SD group at 9 months, but not at 18 months. In all three groups, however, the BMI decreased significantly at 9 months (Fig. <a href="#Fig4" class="usa-link">4</a>A). Waist circumference was 3 cm smaller at 18 months in the KD vs. the SD group (<em>p</em> = 0.044) and decreased within the KD group over time (Fig. <a href="#Fig4" class="usa-link">4</a>B). In line with this, body fat mass (Unstandardized B = − 1.653, <em>p</em> = 0.015) and abdominal fat mass (Unstandardized B = − 2.2, <em>p</em> = 0.008) were lower in the KD vs. the SD group at 9 months, but not at 18 months. In the KD group, abdominal fat mass decreased from 31% at baseline to 26% at 9 and 28% at 18 months. Body cell mass (Unstandardized B = − 1.3, <em>p</em> = 0.022) and fat free mass (Unstandardized B = − 1.2, <em>p</em> = 0.047) were lower in the FD vs. the SD group at 9 months, but not 18 months. Systolic blood pressure decreased in the SD group (Fig. <a href="#Fig4" class="usa-link">4</a>E), while diastolic blood pressure decreased at different time points in the KD and FD group (Fig. <a href="#Fig4" class="usa-link">4</a>F).</p>
<figure class="fig xbox font-sm" id="Fig4"><h5 class="obj_head">Fig. 4.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12366206_40795_2025_1156_Fig4_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea33/12366206/977ee1d903b8/40795_2025_1156_Fig4_HTML.jpg" loading="lazy" id="d33e1643" height="817" width="669" alt="Fig. 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Improved cardiometabolic risk markers in the standard diet (SD, black circles), fasting diet (FD, blue circles) and ketogenic diet (KD, red circles) of the NAMS study (FAS population). (<strong>A</strong>) Body mass index (BMI), (<strong>B</strong>) waist circumference, (<strong>C</strong>) triglycerides and (<strong>D</strong>) LDL cholesterol. Data as median and interquartile range, <em>p</em> values by Wilcoxon signed-rank tests. (<strong>E</strong>) Systolic and (<strong>F</strong>) diastolic blood pressure. Data as mean and standard deviation, <em>p</em> values by t-test</p></figcaption></figure></section><section id="Sec16"><h4 class="pmc_sec_title">Dietary intake</h4>
<p id="Par78">Food records revealed no relevant macro- or micronutrient intake deficiencies in the FD and KD group. The KD group reduced their carbohydrate intake from 40% at baseline to 13% and 20% of energy intake at 9 and 18 months, respectively. Their fat intake increased from 41% at baseline to 65% and 58% of energy intake at 9 and 18 months, respectively. Fiber intake increased in the SD group at 9 months vs. baseline by (+ 9 [<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>] g/d up to 33 [<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>] g/d, <em>p</em> = 0.028) and was higher than in the FD (20 [<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>] g/d) and the KD group (25 [<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>] g/d). At 18 months, fiber intake in the FD group (22 [<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>] g/d) was still lower than in the SD (30 [<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>] g/d) and KD group (27 [<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>] g/d). Comprehensive overviews on dietary intake (macro and micronutrient intake) in all participants and diet groups are displayed in Suppl. Tables <a href="#MOESM1" class="usa-link">6–9</a>.</p></section><section id="Sec17"><h4 class="pmc_sec_title">Safety of the diets and compliance</h4>
<p id="Par79">Eighty-one participants completed the study in the Full Analysis Set (FAS) population, in which all exploratory analyses of secondary endpoints were performed.</p>
<p id="Par80">All diets were well tolerated, and adverse events were mostly mild and transient (total, <em>n</em> = 311; SD, <em>n</em> = 77; FD, <em>n</em> = 115; KD, <em>n</em> = 119). The portion of the groups and types of adverse events can be found in Suppl. Table <a href="#MOESM1" class="usa-link">1</a>. Serious adverse events were not related to the diets (total, <em>n</em> = 11; SD, <em>n</em> = 2; FD, <em>n</em> = 2; KD, <em>n</em> = 7; Suppl. Table <a href="#MOESM1" class="usa-link">2</a>).</p>
<p id="Par81">Attendance rates of dietary sessions were 88%, 100% and 77% in the SD, FD, and KD group, respectively. In the KD group, plasma BHB was ≥ 0.5 mmol/L in 62% of participants at 9 months and in 35% at 18 months, with median concentrations ≥ 0.5 mmol/L, indicating nutritional ketosis on group level at both time points (Fig. <a href="#Fig5" class="usa-link">5</a>).</p>
<figure class="fig xbox font-sm" id="Fig5"><h5 class="obj_head">Fig. 5.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12366206_40795_2025_1156_Fig5_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea33/12366206/e036e302a3c1/40795_2025_1156_Fig5_HTML.jpg" loading="lazy" id="d33e1734" height="507" width="738" alt="Fig. 5"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Adherence in the standard diet (SD, black circles), fasting diet (FD, blue circles) and ketogenic diet (KD, red circles) of the NAMS study. <strong>A</strong>) Blood beta-hydroxybutyrate concentrations confirmed nutritional ketosis in the KD group (FAS population). Data as median and interquartile range, <em>p</em> values by Wilcoxon signed-rank test</p></figcaption></figure></section><section id="Sec18"><h4 class="pmc_sec_title">Predictors and determinants for disease outcomes</h4>
<p id="Par83">Predictors for having at least one new lesion at 18 months could not be identified. BHB blood concentrations were not associated with improved cognition (linear regression analysis, <em>p</em> = 0.734). However, there was a trend for an inverse association between triglyceride concentrations at 9 months and the SDMT score at 18 months in the KD group only (linear regression analysis, adjusted R-square: 0.178, Unstandardized B: − 0.328, <em>p</em> = 0.064). Additionally, there was an inverse correlation between diastolic blood pressure and SDMT scores at 18 months (Pearson correlation, <em>r</em> = − 0.396, <em>p</em> = 0.050) in the KD group, which could be reproduced as a trend in a linear regression (Unstandardized B = − 0.646, <em>p</em> = 0.054). Controlling for body weight, the trend remains (linear regression, Unstandardized B = − 0.626, <em>p</em> = 0.069).</p>
<p id="Par84">The BDI-II score at 18 months was positively associated with body weight at 9 months in the FD group (trend, linear regression, Unstandardized B = 0.231, <em>p</em> = 0.054). Additionally, there was a positive correlation for leptin levels and BDI-II-scores at 18 months in the FD group (linear regression, Unstandardized B = 0.507, <em>p</em> = 0.043), a correlation that remained borderline significant when controlling for body weight (linear regression, Unstandardized B = 0.431, <em>p</em> = 0.059).</p></section></section></section><section id="Sec19"><h2 class="pmc_sec_title">Discussion</h2>
<p id="Par85">To our knowledge the NAMS study is the largest randomized-controlled study investigating in MS ketone-based diets (ketogenic and fasting diet) in comparison to a standard healthy diet.</p>
<section id="Sec20"><h3 class="pmc_sec_title">Primary outcome, MRI outcomes and neurodegeneration markers</h3>
<p id="Par86">We report no disease progression in terms of new cranial MRI lesions in any of the groups after 18 months study duration. Although a recent cohort study reported a relationship of pro-inflammatory diets with lesion volume and relapse rates [<a href="#CR33" class="usa-link" aria-describedby="CR33">33</a>], an anti-inflammatory dietary intervention did not show effects on MRI outcomes in a RCT [<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>]. In contrast, a small randomized-controlled pilot study did show effects of 12-weeks intermittent caloric restriction on cortical volume and thickness [<a href="#CR34" class="usa-link" aria-describedby="CR34">34</a>]. Even though we could not show an additional advantage of FD and KD, the complete lack of new lesions is a favorable result, especially considering the recruitment of people with MS with verified active disease (defined as one new lesion or relapse within the last two years prior to enrolment). In a comparable MS population, within 2 years, there was an increase of 17 new lesions in the placebo group compared to 3–4 new lesions under dimethyl fumarate [<a href="#CR35" class="usa-link" aria-describedby="CR35">35</a>]. Noteworthy, 45% of our participants were on stable DMTs at study inclusion. This leads to a reduction in disease activity per se, which subsequently makes it more difficult to detect any influence on disease activity. However, including participants on different DMTs and no DMTs was unavoidable to ensure recruitment in a reasonable time frame and it certainly reflects real world conditions [<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>].</p>
<p id="Par87">We found a decrease of NfL in the FD group at 9 months. As NfL concentrations correlated well with several MS disease outcomes (EDSS, lesions count, cognition) in our cohort and others [<a href="#CR36" class="usa-link" aria-describedby="CR36">36</a>, <a href="#CR37" class="usa-link" aria-describedby="CR37">37</a>], this decrease may suggest decelerated axonal injury due to fasting [<a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>]. However, subjects with high BHB levels were reported to have a higher degree of improvement in serum NfL concentrations on KD in a study [<a href="#CR39" class="usa-link" aria-describedby="CR39">39</a>].</p></section><section id="Sec21"><h3 class="pmc_sec_title">Patient-centered outcomes</h3>
<p id="Par88">Depressive symptoms, cognitive impairment and fatigue are highly prevalent in MS and may have detrimental effects on patient’s autonomy, socioeconomic status and quality of life [<a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>]. KDs have been shown to improve fatigue in MS, however, the lack of a control group [<a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>] or very small sample sizes [<a href="#CR41" class="usa-link" aria-describedby="CR41">41</a>] limit inferences. Our study participants anecdotally described being less fatigued and more attentive while on KD. Despite, this was not reflected in the FSS scores of the overall groups. This discrepancy might be because the FSS rather queries physical fatigue than mental fatigue. Lower mental fatigue may be reflected by improved SDMT scores (+ 3.7 points at 18 months) in our KD group, a change considered clinically relevant [<a href="#CR42" class="usa-link" aria-describedby="CR42">42</a>]. There were slight effects on depressive symptoms in the FD group.</p>
<p id="Par89">A clinically relevant change of the BDI-II score is reported by a reduction of more than 18% [<a href="#CR43" class="usa-link" aria-describedby="CR43">43</a>]. Our FD group improved by 22%, while our SD group deteriorated by 29%. This is in line with previous data showing improved domains of depressive symptoms due to fasting [<a href="#CR44" class="usa-link" aria-describedby="CR44">44</a>]. In our FD group, body weight was positively associated with depression scores, indicating that this effect might have been mediated by weight reduction. Similar results were reported by Fitzgerald et al. [<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>]. Of note, the BDI-II does not seem to be best suitable for assessing depressive symptoms during dietary interventions, because it queries changes of appetite and sleep, which may be desirable side effects, e.g. in a KD [<a href="#CR45" class="usa-link" aria-describedby="CR45">45</a>, <a href="#CR46" class="usa-link" aria-describedby="CR46">46</a>]. Besides, when interpreting our results, it must be considered that depressive symptoms were only minimally prevalent at baseline in our cohort.</p></section><section id="Sec22"><h3 class="pmc_sec_title">Cardiometabolic health, anthropometry and body composition</h3>
<p id="Par90">Elevated leptin concentrations are prevalent in MS [<a href="#CR47" class="usa-link" aria-describedby="CR47">47</a>], even independently of BMI [<a href="#CR48" class="usa-link" aria-describedby="CR48">48</a>], and are associated with reduced regulatory T-cells [<a href="#CR49" class="usa-link" aria-describedby="CR49">49</a>] as well as with more severe disability, also independently of BMI [<a href="#CR50" class="usa-link" aria-describedby="CR50">50</a>]. In our KD group, leptin decreased, and adiponectin increased in the KD and FD group. In addition, we found a positive association between leptin and depression scores in the FD group, indicating a positive effect of leptin reduction, which has been postulated previously [<a href="#CR51" class="usa-link" aria-describedby="CR51">51</a>]. Our diets had different, but overall beneficial effects on all measured blood lipids, which have been shown repeatedly to be associated with cognition in MS cohorts [<a href="#CR52" class="usa-link" aria-describedby="CR52">52</a>–<a href="#CR55" class="usa-link" aria-describedby="CR55">55</a>]. In addition, NfL concentrations and HDL cholesterol were shown to be inversely correlated, suggesting metabolic alterations to be contributors to MS disease course [<a href="#CR56" class="usa-link" aria-describedby="CR56">56</a>]. Our diets improved markers of cardiometabolic risk, such as body weight and composition, lipid profile, adipokines and blood pressure that are not only prevalent in MS, but also associated with an adverse disease course of MS [<a href="#CR57" class="usa-link" aria-describedby="CR57">57</a>–<a href="#CR59" class="usa-link" aria-describedby="CR59">59</a>]. Especially hypertension affects grey matter atrophy and white matter damage [<a href="#CR60" class="usa-link" aria-describedby="CR60">60</a>]. In line with Motl et al. [<a href="#CR61" class="usa-link" aria-describedby="CR61">61</a>], diastolic blood pressure, which was reduced by 5 mmHg at 18 months in our KD group, was inversely correlated with cognition scores. Vascular comorbidities have been shown to be associated with cognitive dysfunction in MS [<a href="#CR62" class="usa-link" aria-describedby="CR62">62</a>], suggesting a beneficial effect of blood pressure reduction due to dietary interventions.</p></section><section id="Sec23"><h3 class="pmc_sec_title">Dietary intake, safety of the diets and compliance</h3>
<p id="Par91">We show that these dietary approaches are safe with no relevant nutrient deficiencies, and only mild, transient adverse events. Repeated periodic fasting combined with time-restricted eating seemed to be more feasible than continuous reduction of carbohydrate intake, as evidenced by smaller dropout rates in the FD vs. KD group and less adherence in the KD at 18 months. Participants reported that the KD required drastic changes in daily life, much discipline, was time-consuming and socially less acceptable. Anecdotal observations suggest that the challenges posed by the COVID-19 pandemic – such as lockdowns and travel restrictions - added to the psychological burden for patients following an already restrictive diet like the KD. Better adherence to rather time-restricted eating compared to continuous caloric restriction has been shown previously [<a href="#CR63" class="usa-link" aria-describedby="CR63">63</a>]. Adverse events were more frequent in the FD and KD group, however, that may have been biased by increased awareness due to detailed explanation of possible side effects of KD and FD or more frequent meetings in the FD group.</p></section></section><section id="Sec24"><h2 class="pmc_sec_title">Limitations</h2>
<p id="Par92">We planned this study with 111 participants (expected dropout rate 10%) and included 105 participants with an actual overall dropout rate of 21%. We could not show a superiority of KD or FD diets compared to a healthy control diet: we suggest that the healthy standard diet of the control group has already a relevant influence on the disease activity, that it was not inferior to the ketone-based diets. However, for ethical reasons it was reasonable to offer the control group at least the standard dietary treatment, especially over a period of 18 months. Furthermore, even though the overall study population is one of the largest nutritional intervention studies in MS, the group size of each intervention was rather small. Therefore, considering the heterogeneous disease course of our patients and the use of different DMTs of MS, our results need to be replicated in larger and more homogenous follow-up studies. In our study only a modest peripheral ketosis was measured and the full potential of ketone bodies as signaling molecules in the brain has probably not been achieved. In contrast to our study, measurements of ketones in a rather continuous manner such as via using ketone sensors measuring ketone every 15 min in the interstitial, may be more insightful to understand important fluctuations of ketosis and individual responses to foods.</p>
<p id="Par93">Of note, a part of the study took place during the COVID-19 pandemic and was therefore severely affected by travel and contact restrictions, necessitating the change from in-person to online nutritional counselling, which may have affected motivation of study participants leading to higher dropout rates and slowed down recruitment. Additional effects of this turbulent time on our study outcomes such as on mental health cannot be ruled out. As dietary interventions are by nature unblinded, we aimed to minimize placebo effects by not communicating any interim results to participants, However, placebo effects, especially regarding patient-reported outcomes cannot be ruled out.</p></section><section id="Sec25"><h2 class="pmc_sec_title">Conclusion</h2>
<p id="Par94">The three group-based dietary interventions examined in this study were associated with a stable MS disease course and improvements in cardiometabolic health. A trend was observed suggesting that the ketogenic diet may positively influence cognitive function, while the fasting diet may alleviate depressive symptoms. Overall, the findings suggest beneficial effects of dietary interventions, supporting their potential role as complementary strategies in the management of RRMS. These results warrant further investigation in larger and more homogeneous study populations to allow for definitive conclusions.</p></section><section id="Sec27"><h2 class="pmc_sec_title">Supplementary Information</h2>
<p>Below is the link to the electronic supplementary material.</p>
<section class="sm xbox font-sm" id="MOESM1"><div class="media p"><div class="caption">
<a href="/articles/instance/12366206/bin/40795_2025_1156_MOESM1_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">40795_2025_1156_MOESM1_ESM.docx</a><sup> (114.9KB, docx) </sup><p><strong>Supplementary Material 1</strong>: <strong>Suppl. Table 1</strong>. Adverse events in the Intention-to-Treat population of the NAMS study. <strong>Suppl. Table 2.</strong> Serious adverse events in the Intention-to-Treat population of the NAMS study. <strong>Suppl. Table 3.</strong> Outcome data of the NAMS study at baseline in the Full Analysis Set (FAS). <strong>Suppl. Table 4.</strong> Outcome data of the NAMS at 9 months in the Full Analysis Set (FAS). <strong>Suppl. Table 5.</strong> Outcome data of the NAMS at 18 months in the Full Analysis Set (FAS). <strong>Suppl. Table 6.</strong> Dietary intake data for all participants. <strong>Suppl. Table 7.</strong> Dietary intake data for standard diet group. <strong>Suppl. Table 8.</strong> Dietary intake data for fasting diet group. <strong>Suppl. Table 9.</strong> Dietary intake data for ketogenic diet group. <strong>Suppl. Table 10.</strong> CONSERVE Checklist.</p>
</div></div></section><section class="sm xbox font-sm" id="MOESM2"><div class="media p"><div class="caption">
<a href="/articles/instance/12366206/bin/40795_2025_1156_MOESM2_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 2</a><sup> (20.4KB, docx) </sup>
</div></div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>We thank Claudia Messelhäußer and Bibiane Seeger-Schwinger for carrying out study visits and for laboratory pre-analytics, Susan Pikol and Cynthia Kraut for MRI T2-lesion segmentations, and Dania Schumann, Alexandra Prüß, Elektra Polychronidou for their engagement in carrying out the dietary sessions.</p></section><section id="glossary1" class="glossary"><h2 class="pmc_sec_title">Abbreviations</h2>
<dl class="def-list">
<dt>BDI</dt>
<dd><p id="Par6">Beck depression inventory</p></dd>
<dt>BHB</dt>
<dd><p id="Par7">Beta-hydroxybutyrate</p></dd>
<dt>BMI</dt>
<dd><p id="Par8">Body mass index</p></dd>
<dt>DMT</dt>
<dd><p id="Par9">Disease modifying therapy</p></dd>
<dt>EAE</dt>
<dd><p id="Par10">Experimental autoimmune encephalomyelitis</p></dd>
<dt>EDSS</dt>
<dd><p id="Par11">Expanded disability status scale</p></dd>
<dt>FAS</dt>
<dd><p id="Par12">Full analysis set</p></dd>
<dt>FSS</dt>
<dd><p id="Par13">Fatigue severity scale</p></dd>
<dt>FD</dt>
<dd><p id="Par14">Fasting diet</p></dd>
<dt>ITT</dt>
<dd><p id="Par15">Intention-to-treat</p></dd>
<dt>IQR</dt>
<dd><p id="Par16">Interquartile range</p></dd>
<dt>KD</dt>
<dd><p id="Par17">Ketogenic diet</p></dd>
<dt>MRI</dt>
<dd><p id="Par18">Magnetic resonance imaging</p></dd>
<dt>MS</dt>
<dd><p id="Par19">Multiple sclerosis</p></dd>
<dt>MSFC</dt>
<dd><p id="Par20">Multiple sclerosis functional composite</p></dd>
<dt>NAMS</dt>
<dd><p id="Par21">Nutritional approaches in multiple Sclerosis</p></dd>
<dt>NfL</dt>
<dd><p id="Par22">Neurofilament light chain</p></dd>
<dt>PP</dt>
<dd><p id="Par23">Per protocol</p></dd>
<dt>QoL</dt>
<dd><p id="Par24">Quality of life</p></dd>
<dt>RRMS</dt>
<dd><p id="Par25">Relapsing-remitting multiple sclerosis</p></dd>
<dt>SD</dt>
<dd><p id="Par26">Standard diet</p></dd>
<dt>SDMT</dt>
<dd><p id="Par27">Symbol digit modalities test</p></dd>
<dt>StD</dt>
<dd><p id="Par28">Standard deviation</p></dd>
</dl></section><section id="notes1"><h2 class="pmc_sec_title">Author contributions</h2>
<p>JBS, MB, AM, FP, AMä designed the study. LSB, DK, MB, AMä developed the interventional concept and accompanied the interventions during the course of the study. LSB, AM, FP and AMä procured funding. AK, JM, LSB, MO, JS applied statistical analyses. MS and CC carried out MRI data management and extracted MRI metrics. LBS, TSH, RR carried out study visits and data management. LSB and AMä wrote the manuscript. All authors read and approved the final version.</p></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>Open Access funding enabled and organized by Projekt DEAL. Walter and Ilse Rose-foundation and Myelin project partially funded the study. The funders had no roles in the conceptualization, design, data collection, analysis, decision to publish, or preparation of the manuscript.</p></section><section id="notes3"><h2 class="pmc_sec_title">Data availability</h2>
<p>The datasets used and analysed during the current study available from the corresponding author on reasonable request. Requests can be directed to lina.bahr@charite.de.</p></section><section id="notes4"><h2 class="pmc_sec_title">Declarations</h2>
<section id="FPar1"><h3 class="pmc_sec_title">Ethics approval and consent to participate</h3>
<p id="Par95">The study was approved by the institutional review board of Charité – Universitätsmedizin Berlin (EA1/200/16). All research was performed in accordance with relevant guidelines/regulations and in accordance with the Declaration of Helsinki. Informed consent was obtained from all participants after screening to take part in the study and that pseudonymized data can be published.</p></section><section id="FPar2"><h3 class="pmc_sec_title">Consent for publication</h3>
<p id="Par96">Not applicable.</p></section><section id="FPar3"><h3 class="pmc_sec_title">Competing interests</h3>
<p id="Par97">Daniela A. Koppold and Andreas Michalsen are members of the steering committee of the Medical Association for Fasting and Nutrition (ÄGHE). They have also co-founded the Academy of Integrative Fasting (AIF), an institution for the qualification of medical staff in clinical fasting applications. D.A.K. serves as a consultant for a mobile application on intermittent fasting (FASTIC) as well as a company producing plant-based supplements (FENOU).  A.M. is also Co-founder of the SALUFAST company. A.M. serves as a consultant for Lanserhof. The funders of the study were neither involved in the study design nor the interpretation of data or the publishing of the results.</p></section></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm">
<div class="fn p" id="fn1">
<p><strong>Publisher’s note</strong></p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</div>
<div class="fn p" id="fn2"><p>Lina S. Bahr and Judith Bellmann-Strobl these authors contributed equally to this work and share first authorship.</p></div>
<div class="fn p" id="fn3"><p>Andreas Michalsen, Friedemann Paul and Anja Mähler these authors contributed equally to this work and share senior authorship.</p></div>
</div></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CR1">
<span class="label">1.</span><cite>Wekerle H. Nature, nurture, and microbes: the development of multiple sclerosis. Acta Neurol Scand. 2017;136(Suppl 201):22–5.
</cite> [<a href="https://doi.org/10.1111/ane.12843" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29068487/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wekerle%20H.%20Nature,%20nurture,%20and%20microbes:%20the%20development%20of%20multiple%20sclerosis.%20Acta%20Neurol%20Scand.%202017;136(Suppl%20201):22%E2%80%935." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<span class="label">2.</span><cite>Mische LJ, Mowry EM. The evidence for dietary interventions and nutritional supplements as treatment options in multiple sclerosis: a review. Curr Treat Options Neurol. 2018;20(4):8.
</cite> [<a href="https://doi.org/10.1007/s11940-018-0494-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29549521/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mische%20LJ,%20Mowry%20EM.%20The%20evidence%20for%20dietary%20interventions%20and%20nutritional%20supplements%20as%20treatment%20options%20in%20multiple%20sclerosis:%20a%20review.%20Curr%20Treat%20Options%20Neurol.%202018;20(4):8." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR3">
<span class="label">3.</span><cite>Mousavi-Shirazi-Fard Z, Mazloom Z, Izadi S, Fararouei M. The effects of modified anti-inflammatory diet on fatigue, quality of life, and inflammatory biomarkers in relapsing-remitting multiple sclerosis patients: a randomized clinical trial. Int J Neurosci. 2021;131(7):657–65.
</cite> [<a href="https://doi.org/10.1080/00207454.2020.1750398" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32249637/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mousavi-Shirazi-Fard%20Z,%20Mazloom%20Z,%20Izadi%20S,%20Fararouei%20M.%20The%20effects%20of%20modified%20anti-inflammatory%20diet%20on%20fatigue,%20quality%20of%20life,%20and%20inflammatory%20biomarkers%20in%20relapsing-remitting%20multiple%20sclerosis%20patients:%20a%20randomized%20clinical%20trial.%20Int%20J%20Neurosci.%202021;131(7):657%E2%80%9365." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<span class="label">4.</span><cite>Yadav V, Marracci G, Kim E, Spain R, Cameron M, Overs S, Riddehough A, Li DK, McDougall J, Lovera J, Murchison C, Bourdette D. Low-fat, plant-based diet in multiple sclerosis: A randomized controlled trial. Mult Scler Relat Disord. 2016;9:80–90.
</cite> [<a href="https://doi.org/10.1016/j.msard.2016.07.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27645350/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yadav%20V,%20Marracci%20G,%20Kim%20E,%20Spain%20R,%20Cameron%20M,%20Overs%20S,%20Riddehough%20A,%20Li%20DK,%20McDougall%20J,%20Lovera%20J,%20Murchison%20C,%20Bourdette%20D.%20Low-fat,%20plant-based%20diet%20in%20multiple%20sclerosis:%20A%20randomized%20controlled%20trial.%20Mult%20Scler%20Relat%20Disord.%202016;9:80%E2%80%9390." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<span class="label">5.</span><cite>Storoni M, Plant GT. The therapeutic potential of the ketogenic diet in treating progressive multiple sclerosis. Mult Scler Int. 2015;2015:681289.
</cite> [<a href="https://doi.org/10.1155/2015/681289" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4709725/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26839705/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Storoni%20M,%20Plant%20GT.%20The%20therapeutic%20potential%20of%20the%20ketogenic%20diet%20in%20treating%20progressive%20multiple%20sclerosis.%20Mult%20Scler%20Int.%202015;2015:681289." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR6">
<span class="label">6.</span><cite>Piccio L, Stark JL, Cross AH. Chronic calorie restriction attenuates experimental autoimmune encephalomyelitis. J Leukoc Biol. 2008;84(4):940–8.
</cite> [<a href="https://doi.org/10.1189/jlb.0208133" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2638732/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18678605/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Piccio%20L,%20Stark%20JL,%20Cross%20AH.%20Chronic%20calorie%20restriction%20attenuates%20experimental%20autoimmune%20encephalomyelitis.%20J%20Leukoc%20Biol.%202008;84(4):940%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR7">
<span class="label">7.</span><cite>Kafami L, Raza M, Razavi A, Mirshafiey A, Movahedian M, Khorramizadeh MR. Intermittent feeding attenuates clinical course of experimental autoimmune encephalomyelitis in C57BL/6 mice. Avicenna J Med Biotechnol. 2010;2(1):47–52.
</cite> [<a href="/articles/PMC3558143/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23407146/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kafami%20L,%20Raza%20M,%20Razavi%20A,%20Mirshafiey%20A,%20Movahedian%20M,%20Khorramizadeh%20MR.%20Intermittent%20feeding%20attenuates%20clinical%20course%20of%20experimental%20autoimmune%20encephalomyelitis%20in%20C57BL/6%20mice.%20Avicenna%20J%20Med%20Biotechnol.%202010;2(1):47%E2%80%9352." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR8">
<span class="label">8.</span><cite>Razeghi Jahromi S, Ghaemi A, Alizadeh A, Sabetghadam F, Moradi Tabriz H, Togha M. Effects of intermittent fasting on experimental autoimune encephalomyelitis in C57BL/6 mice. Iran J Allergy Asthma Immunol. 2016;15(3):212–9.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/27424136/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Razeghi%20Jahromi%20S,%20Ghaemi%20A,%20Alizadeh%20A,%20Sabetghadam%20F,%20Moradi%20Tabriz%20H,%20Togha%20M.%20Effects%20of%20intermittent%20fasting%20on%20experimental%20autoimune%20encephalomyelitis%20in%20C57BL/6%20mice.%20Iran%20J%20Allergy%20Asthma%20Immunol.%202016;15(3):212%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR9">
<span class="label">9.</span><cite>Fitzgerald KC, Vizthum D, Henry-Barron B, Schweitzer A, Cassard SD, Kossoff E, Hartman AL, Kapogiannis D, Sullivan P, Baer DJ, Mattson MP, Appel LJ, Mowry EM. Effect of intermittent vs. daily calorie restriction on changes in weight and patient-reported outcomes in people with multiple sclerosis. Mult Scler Relat Disord. 2018;23:33–9.
</cite> [<a href="https://doi.org/10.1016/j.msard.2018.05.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6107078/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29753994/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fitzgerald%20KC,%20Vizthum%20D,%20Henry-Barron%20B,%20Schweitzer%20A,%20Cassard%20SD,%20Kossoff%20E,%20Hartman%20AL,%20Kapogiannis%20D,%20Sullivan%20P,%20Baer%20DJ,%20Mattson%20MP,%20Appel%20LJ,%20Mowry%20EM.%20Effect%20of%20intermittent%20vs.%20daily%20calorie%20restriction%20on%20changes%20in%20weight%20and%20patient-reported%20outcomes%20in%20people%20with%20multiple%20sclerosis.%20Mult%20Scler%20Relat%20Disord.%202018;23:33%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR10">
<span class="label">10.</span><cite>Winesett SP, Bessone SK, Kossoff EH. The ketogenic diet in pharmacoresistant childhood epilepsy. Expert Rev Neurother. 2015;15(6):621–8.
</cite> [<a href="https://doi.org/10.1586/14737175.2015.1044982" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25994046/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Winesett%20SP,%20Bessone%20SK,%20Kossoff%20EH.%20The%20ketogenic%20diet%20in%20pharmacoresistant%20childhood%20epilepsy.%20Expert%20Rev%20Neurother.%202015;15(6):621%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR11">
<span class="label">11.</span><cite>Kossoff EH. More fat and fewer seizures: dietary therapies for epilepsy. Lancet Neurol. 2004;3(7):415–20.
</cite> [<a href="https://doi.org/10.1016/S1474-4422(04)00807-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15207798/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kossoff%20EH.%20More%20fat%20and%20fewer%20seizures:%20dietary%20therapies%20for%20epilepsy.%20Lancet%20Neurol.%202004;3(7):415%E2%80%9320." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR12">
<span class="label">12.</span><cite>Reger MA, Henderson ST, Hale C, Cholerton B, Baker LD, Watson GS, Hyde K, Chapman D, Craft S. Effects of beta-hydroxybutyrate on cognition in memory-impaired adults. Neurobiol Aging. 2004;25(3):311–4.
</cite> [<a href="https://doi.org/10.1016/S0197-4580(03)00087-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15123336/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Reger%20MA,%20Henderson%20ST,%20Hale%20C,%20Cholerton%20B,%20Baker%20LD,%20Watson%20GS,%20Hyde%20K,%20Chapman%20D,%20Craft%20S.%20Effects%20of%20beta-hydroxybutyrate%20on%20cognition%20in%20memory-impaired%20adults.%20Neurobiol%20Aging.%202004;25(3):311%E2%80%934." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR13">
<span class="label">13.</span><cite>Vanitallie TB, Nonas C, Di Rocco A, Boyar K, Hyams K, Heymsfield SB. Treatment of Parkinson disease with diet-induced hyperketonemia: a feasibility study. Neurology. 2005;64(4):728–30.
</cite> [<a href="https://doi.org/10.1212/01.WNL.0000152046.11390.45" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15728303/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Vanitallie%20TB,%20Nonas%20C,%20Di%20Rocco%20A,%20Boyar%20K,%20Hyams%20K,%20Heymsfield%20SB.%20Treatment%20of%20Parkinson%20disease%20with%20diet-induced%20hyperketonemia:%20a%20feasibility%20study.%20Neurology.%202005;64(4):728%E2%80%9330." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR14">
<span class="label">14.</span><cite>Kim DY, Hao J, Liu R, Turner G, Shi FD, Rho JM. Inflammation-mediated memory dysfunction and effects of a ketogenic diet in a murine model of multiple sclerosis. PLoS ONE. 2012;7(5):e35476.
</cite> [<a href="https://doi.org/10.1371/journal.pone.0035476" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3342287/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22567104/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kim%20DY,%20Hao%20J,%20Liu%20R,%20Turner%20G,%20Shi%20FD,%20Rho%20JM.%20Inflammation-mediated%20memory%20dysfunction%20and%20effects%20of%20a%20ketogenic%20diet%20in%20a%20murine%20model%20of%20multiple%20sclerosis.%20PLoS%20ONE.%202012;7(5):e35476." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<span class="label">15.</span><cite>Choi IY, Piccio L, Childress P, Bollman B, Ghosh A, Brandhorst S, Suarez J, Michalsen A, Cross AH, Morgan TE, Wei M, Paul F, Bock M, Longo VD. A diet mimicking fasting promotes regeneration and reduces autoimmunity and multiple sclerosis symptoms. Cell Rep. 2016;15(10):2136–46.
</cite> [<a href="https://doi.org/10.1016/j.celrep.2016.05.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4899145/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27239035/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Choi%20IY,%20Piccio%20L,%20Childress%20P,%20Bollman%20B,%20Ghosh%20A,%20Brandhorst%20S,%20Suarez%20J,%20Michalsen%20A,%20Cross%20AH,%20Morgan%20TE,%20Wei%20M,%20Paul%20F,%20Bock%20M,%20Longo%20VD.%20A%20diet%20mimicking%20fasting%20promotes%20regeneration%20and%20reduces%20autoimmunity%20and%20multiple%20sclerosis%20symptoms.%20Cell%20Rep.%202016;15(10):2136%E2%80%9346." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR16">
<span class="label">16.</span><cite>Brenton JN, Banwell B, Bergqvist AGC, Lehner-Gulotta D, Gampper L, Leytham E, Coleman R, Goldman MD. Pilot study of a ketogenic diet in relapsing-remitting MS. Neurol Neuroimmunol Neuroinflamm. 2019;6(4):e565.
</cite> [<a href="https://doi.org/10.1212/NXI.0000000000000565" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6487505/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31089482/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Brenton%20JN,%20Banwell%20B,%20Bergqvist%20AGC,%20Lehner-Gulotta%20D,%20Gampper%20L,%20Leytham%20E,%20Coleman%20R,%20Goldman%20MD.%20Pilot%20study%20of%20a%20ketogenic%20diet%20in%20relapsing-remitting%20MS.%20Neurol%20Neuroimmunol%20Neuroinflamm.%202019;6(4):e565." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR17">
<span class="label">17.</span><cite>Brenton JN, Lehner-Gulotta D, Woolbright E, Banwell B, Bergqvist AGC, Chen S, Coleman R, Conaway M, Goldman MD. Phase II study of ketogenic diets in relapsing multiple sclerosis: safety, tolerability and potential clinical benefits. J Neurol Neurosurg Psychiatry. 2022;93(6):637–44.
</cite> [<a href="https://doi.org/10.1136/jnnp-2022-329074" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9350909/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35418509/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Brenton%20JN,%20Lehner-Gulotta%20D,%20Woolbright%20E,%20Banwell%20B,%20Bergqvist%20AGC,%20Chen%20S,%20Coleman%20R,%20Conaway%20M,%20Goldman%20MD.%20Phase%20II%20study%20of%20ketogenic%20diets%20in%20relapsing%20multiple%20sclerosis:%20safety,%20tolerability%20and%20potential%20clinical%20benefits.%20J%20Neurol%20Neurosurg%20Psychiatry.%202022;93(6):637%E2%80%9344." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR18">
<span class="label">18.</span><cite>Bahr LS, Bock M, Liebscher D, Bellmann-Strobl J, Franz L, Pruss A, Schumann D, Piper SK, Kessler CS, Steckhan N, Michalsen A, Paul F, Mahler A. Ketogenic diet and fasting diet as nutritional approaches in multiple sclerosis (NAMS): protocol of a randomized controlled study. Trials. 2020;21(1):3.
</cite> [<a href="https://doi.org/10.1186/s13063-019-3928-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6941322/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31898518/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bahr%20LS,%20Bock%20M,%20Liebscher%20D,%20Bellmann-Strobl%20J,%20Franz%20L,%20Pruss%20A,%20Schumann%20D,%20Piper%20SK,%20Kessler%20CS,%20Steckhan%20N,%20Michalsen%20A,%20Paul%20F,%20Mahler%20A.%20Ketogenic%20diet%20and%20fasting%20diet%20as%20nutritional%20approaches%20in%20multiple%20sclerosis%20(NAMS):%20protocol%20of%20a%20randomized%20controlled%20study.%20Trials.%202020;21(1):3." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR19">
<span class="label">19.</span><cite>Bahr LS. Effects of fasting and a ketogenic diet on neuropsychiatric outcomes in multiple sclerosis patients – a randomized controlled trial. Charié - Universitätsmedizin Berlin 2022.</cite>
</li>
<li id="CR20">
<span class="label">20.</span><cite>Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, Correale J, Fazekas F, Filippi M, Freedman MS, Fujihara K, Galetta SL, Hartung HP, Kappos L, Lublin FD, Marrie RA, Miller AE, Miller DH, Montalban X, Mowry EM, Sorensen PS, Tintore M, Traboulsee AL, Trojano M, Uitdehaag BMJ, Vukusic S, Waubant E, Weinshenker BG, Reingold SC, Cohen JA. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162–73.
</cite> [<a href="https://doi.org/10.1016/S1474-4422(17)30470-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29275977/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Thompson%20AJ,%20Banwell%20BL,%20Barkhof%20F,%20Carroll%20WM,%20Coetzee%20T,%20Comi%20G,%20Correale%20J,%20Fazekas%20F,%20Filippi%20M,%20Freedman%20MS,%20Fujihara%20K,%20Galetta%20SL,%20Hartung%20HP,%20Kappos%20L,%20Lublin%20FD,%20Marrie%20RA,%20Miller%20AE,%20Miller%20DH,%20Montalban%20X,%20Mowry%20EM,%20Sorensen%20PS,%20Tintore%20M,%20Traboulsee%20AL,%20Trojano%20M,%20Uitdehaag%20BMJ,%20Vukusic%20S,%20Waubant%20E,%20Weinshenker%20BG,%20Reingold%20SC,%20Cohen%20JA.%20Diagnosis%20of%20multiple%20sclerosis:%202017%20revisions%20of%20the%20McDonald%20criteria.%20Lancet%20Neurol.%202018;17(2):162%E2%80%9373." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR21">
<span class="label">21.</span><cite>Wilhelmi de Toledo F, Buchinger A, Burggrabe H, Holz G, Kuhn C, Lischka E, Lischka N, Lutzner H, May W, Ritzmann-Widderich M, Stange R, Wessel A, Boschmann M, Peper E, Michalsen A. Medical association for F, nutrition. Fasting therapy - an expert panel update of the 2002 consensus guidelines. Forsch Komplementmed. 2013;20(6):434–43.
</cite> [<a href="https://doi.org/10.1159/000357602" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24434758/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wilhelmi%20de%20Toledo%20F,%20Buchinger%20A,%20Burggrabe%20H,%20Holz%20G,%20Kuhn%20C,%20Lischka%20E,%20Lischka%20N,%20Lutzner%20H,%20May%20W,%20Ritzmann-Widderich%20M,%20Stange%20R,%20Wessel%20A,%20Boschmann%20M,%20Peper%20E,%20Michalsen%20A.%20Medical%20association%20for%20F,%20nutrition.%20Fasting%20therapy%20-%20an%20expert%20panel%20update%20of%20the%202002%20consensus%20guidelines.%20Forsch%20Komplementmed.%202013;20(6):434%E2%80%9343." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR22">
<span class="label">22.</span><cite>Hamilton GF, McDonald C, Chenier TC. Measurement of grip strength: validity and reliability of the sphygmomanometer and Jamar grip dynamometer. J Orthop Sports Phys Ther. 1992;16(5):215–9.
</cite> [<a href="https://doi.org/10.2519/jospt.1992.16.5.215" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18796752/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hamilton%20GF,%20McDonald%20C,%20Chenier%20TC.%20Measurement%20of%20grip%20strength:%20validity%20and%20reliability%20of%20the%20sphygmomanometer%20and%20Jamar%20grip%20dynamometer.%20J%20Orthop%20Sports%20Phys%20Ther.%201992;16(5):215%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR23">
<span class="label">23.</span><cite>Goldman MD, Marrie RA, Cohen JA. Evaluation of the six-minute walk in multiple sclerosis subjects and healthy controls. Mult Scler. 2008;14(3):383–90.
</cite> [<a href="https://doi.org/10.1177/1352458507082607" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17942508/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Goldman%20MD,%20Marrie%20RA,%20Cohen%20JA.%20Evaluation%20of%20the%20six-minute%20walk%20in%20multiple%20sclerosis%20subjects%20and%20healthy%20controls.%20Mult%20Scler.%202008;14(3):383%E2%80%9390." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR24">
<span class="label">24.</span><cite>Fischer JS, Rudick RA, Cutter GR, Reingold SC. The multiple sclerosis functional composite measure (MSFC): an integrated approach to MS clinical outcome assessment. National MS society clinical outcomes assessment task force. Mult Scler. 1999;5(4):244–50.
</cite> [<a href="https://doi.org/10.1177/135245859900500409" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10467383/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fischer%20JS,%20Rudick%20RA,%20Cutter%20GR,%20Reingold%20SC.%20The%20multiple%20sclerosis%20functional%20composite%20measure%20(MSFC):%20an%20integrated%20approach%20to%20MS%20clinical%20outcome%20assessment.%20National%20MS%20society%20clinical%20outcomes%20assessment%20task%20force.%20Mult%20Scler.%201999;5(4):244%E2%80%9350." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR25">
<span class="label">25.</span><cite>Smith A. Symbol digit modalities test (Revised). Western Psychological Services. 1982.</cite>
</li>
<li id="CR26">
<span class="label">26.</span><cite>Aaron T, Beck RAS, Gregory K. Brown. Beck Depression Inventory – 2nd Edition (BDI-II)1996.</cite>
</li>
<li id="CR27">
<span class="label">27.</span><cite>Wintjen L, Petermann F. Beck-Depressions-Inventar revision (BDI-II). Z Psychiatr Psych Ps. 2010;58(3):243–5.</cite> [<a href="https://scholar.google.com/scholar_lookup?Wintjen%20L,%20Petermann%20F.%20Beck-Depressions-Inventar%20revision%20(BDI-II).%20Z%20Psychiatr%20Psych%20Ps.%202010;58(3):243%E2%80%935." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR28">
<span class="label">28.</span><cite>Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989;46(10):1121–3.
</cite> [<a href="https://doi.org/10.1001/archneur.1989.00520460115022" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/2803071/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Krupp%20LB,%20LaRocca%20NG,%20Muir-Nash%20J,%20Steinberg%20AD.%20The%20fatigue%20severity%20scale.%20Application%20to%20patients%20with%20multiple%20sclerosis%20and%20systemic%20lupus%20erythematosus.%20Arch%20Neurol.%201989;46(10):1121%E2%80%933." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR29">
<span class="label">29.</span><cite>Vickrey BG, Hays RD, Harooni R, Myers LW, Ellison GW. A health-related quality of life measure for multiple sclerosis. Qual Life Res. 1995;4(3):187–206.
</cite> [<a href="https://doi.org/10.1007/BF02260859" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7613530/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Vickrey%20BG,%20Hays%20RD,%20Harooni%20R,%20Myers%20LW,%20Ellison%20GW.%20A%20health-related%20quality%20of%20life%20measure%20for%20multiple%20sclerosis.%20Qual%20Life%20Res.%201995;4(3):187%E2%80%93206." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR30">
<span class="label">30.</span><cite>Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O’Neal L, McLeod L, Delacqua G, Delacqua F, Kirby J, Duda SN, Consortium RE. The REDCap consortium: Building an international community of software platform partners. J Biomed Inf. 2019;95:103208.</cite> [<a href="https://doi.org/10.1016/j.jbi.2019.103208" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7254481/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31078660/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Harris%20PA,%20Taylor%20R,%20Minor%20BL,%20Elliott%20V,%20Fernandez%20M,%20O%E2%80%99Neal%20L,%20McLeod%20L,%20Delacqua%20G,%20Delacqua%20F,%20Kirby%20J,%20Duda%20SN,%20Consortium%20RE.%20The%20REDCap%20consortium:%20Building%20an%20international%20community%20of%20software%20platform%20partners.%20J%20Biomed%20Inf.%202019;95:103208." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR31">
<span class="label">31.</span><cite>Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inf. 2009;42(2):377–81.</cite> [<a href="https://doi.org/10.1016/j.jbi.2008.08.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2700030/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18929686/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Harris%20PA,%20Taylor%20R,%20Thielke%20R,%20Payne%20J,%20Gonzalez%20N,%20Conde%20JG.%20Research%20electronic%20data%20capture%20(REDCap)--a%20metadata-driven%20methodology%20and%20workflow%20process%20for%20providing%20translational%20research%20informatics%20support.%20J%20Biomed%20Inf.%202009;42(2):377%E2%80%9381." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR32">
<span class="label">32.</span><cite>R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. 2023 [Available from: <a href="https://www.R-project.org/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.R-project.org/</a></cite>
</li>
<li id="CR33">
<span class="label">33.</span><cite>Saul AM, Taylor BV, Blizzard L, Simpson-Yap S, Oddy WH, Shivappa N, Hébert JR, Black LJ, Ponsonby AL, Broadley SA, Lechner-Scott J, van der Mei I, Investigators AA. A pro-inflammatory diet in people with multiple sclerosis is associated with an increased rate of relapse and increased FLAIR lesion volume on MRI in early multiple sclerosis: A prospective cohort study. Mult Scler J. 2023;29(8):1012–23.</cite> [<a href="https://doi.org/10.1177/13524585231167739" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10338707/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37148166/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Saul%20AM,%20Taylor%20BV,%20Blizzard%20L,%20Simpson-Yap%20S,%20Oddy%20WH,%20Shivappa%20N,%20H%C3%A9bert%20JR,%20Black%20LJ,%20Ponsonby%20AL,%20Broadley%20SA,%20Lechner-Scott%20J,%20van%20der%20Mei%20I,%20Investigators%20AA.%20A%20pro-inflammatory%20diet%20in%20people%20with%20multiple%20sclerosis%20is%20associated%20with%20an%20increased%20rate%20of%20relapse%20and%20increased%20FLAIR%20lesion%20volume%20on%20MRI%20in%20early%20multiple%20sclerosis:%20A%20prospective%20cohort%20study.%20Mult%20Scler%20J.%202023;29(8):1012%E2%80%9323." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR34">
<span class="label">34.</span><cite>Rahmani F, Ghezzi L, Tosti V, Liu J, Song SK, Wu AT, Rajamanickam J, Obert KA, Benzinger TLS, Mittendorfer B, Piccio L, Raji CA. Twelve weeks of intermittent caloric restriction diet mitigates neuroinflammation in midlife individuals with multiple sclerosis: A pilot study with implications for prevention of alzheimer’s disease. J Alzheimers Dis. 2023;93(1):263–73.
</cite> [<a href="https://doi.org/10.3233/JAD-221007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10460547/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37005885/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Rahmani%20F,%20Ghezzi%20L,%20Tosti%20V,%20Liu%20J,%20Song%20SK,%20Wu%20AT,%20Rajamanickam%20J,%20Obert%20KA,%20Benzinger%20TLS,%20Mittendorfer%20B,%20Piccio%20L,%20Raji%20CA.%20Twelve%20weeks%20of%20intermittent%20caloric%20restriction%20diet%20mitigates%20neuroinflammation%20in%20midlife%20individuals%20with%20multiple%20sclerosis:%20A%20pilot%20study%20with%20implications%20for%20prevention%20of%20alzheimer%E2%80%99s%20disease.%20J%20Alzheimers%20Dis.%202023;93(1):263%E2%80%9373." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR35">
<span class="label">35.</span><cite>Gold R, Kappos L, Arnold DL, Bar-Or A, Giovannoni G, Selmaj K, Tornatore C, Sweetser MT, Yang M, Sheikh SI, Dawson KT, Investigators DS. Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis. N Engl J Med. 2012;367(12):1098–107.
</cite> [<a href="https://doi.org/10.1056/NEJMoa1114287" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22992073/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gold%20R,%20Kappos%20L,%20Arnold%20DL,%20Bar-Or%20A,%20Giovannoni%20G,%20Selmaj%20K,%20Tornatore%20C,%20Sweetser%20MT,%20Yang%20M,%20Sheikh%20SI,%20Dawson%20KT,%20Investigators%20DS.%20Placebo-controlled%20phase%203%20study%20of%20oral%20BG-12%20for%20relapsing%20multiple%20sclerosis.%20N%20Engl%20J%20Med.%202012;367(12):1098%E2%80%93107." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR36">
<span class="label">36.</span><cite>Kuhle J, Plavina T, Barro C, Disanto G, Sangurdekar D, Singh CM, de Moor C, Engle B, Kieseier BC, Fisher E, Kappos L, Rudick RA, Goyal J. Neurofilament light levels are associated with long-term outcomes in multiple sclerosis. Mult Scler. 2020;26(13):1691–9.
</cite> [<a href="https://doi.org/10.1177/1352458519885613" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7604552/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31680621/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kuhle%20J,%20Plavina%20T,%20Barro%20C,%20Disanto%20G,%20Sangurdekar%20D,%20Singh%20CM,%20de%20Moor%20C,%20Engle%20B,%20Kieseier%20BC,%20Fisher%20E,%20Kappos%20L,%20Rudick%20RA,%20Goyal%20J.%20Neurofilament%20light%20levels%20are%20associated%20with%20long-term%20outcomes%20in%20multiple%20sclerosis.%20Mult%20Scler.%202020;26(13):1691%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR37">
<span class="label">37.</span><cite>Harris S, Comi G, Cree BAC, Arnold DL, Steinman L, Sheffield JK, Southworth H, Kappos L, Cohen JA, Investigators OS. Plasma neurofilament light chain concentrations as a biomarker of clinical and radiologic outcomes in relapsing multiple sclerosis: post hoc analysis of phase 3 ozanimod trials. Eur J Neurol. 2021;28(11):3722–30.
</cite> [<a href="https://doi.org/10.1111/ene.15009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9291872/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34292643/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Harris%20S,%20Comi%20G,%20Cree%20BAC,%20Arnold%20DL,%20Steinman%20L,%20Sheffield%20JK,%20Southworth%20H,%20Kappos%20L,%20Cohen%20JA,%20Investigators%20OS.%20Plasma%20neurofilament%20light%20chain%20concentrations%20as%20a%20biomarker%20of%20clinical%20and%20radiologic%20outcomes%20in%20relapsing%20multiple%20sclerosis:%20post%20hoc%20analysis%20of%20phase%203%20ozanimod%20trials.%20Eur%20J%20Neurol.%202021;28(11):3722%E2%80%9330." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR38">
<span class="label">38.</span><cite>Kuhle J, Kropshofer H, Haering DA, Kundu U, Meinert R, Barro C, Dahlke F, Tomic D, Leppert D, Kappos L. Blood neurofilament light chain as a biomarker of MS disease activity and treatment response. Neurology. 2019;92(10):E1007–15.
</cite> [<a href="https://doi.org/10.1212/WNL.0000000000007032" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6442011/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30737333/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kuhle%20J,%20Kropshofer%20H,%20Haering%20DA,%20Kundu%20U,%20Meinert%20R,%20Barro%20C,%20Dahlke%20F,%20Tomic%20D,%20Leppert%20D,%20Kappos%20L.%20Blood%20neurofilament%20light%20chain%20as%20a%20biomarker%20of%20MS%20disease%20activity%20and%20treatment%20response.%20Neurology.%202019;92(10):E1007%E2%80%9315." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR39">
<span class="label">39.</span><cite>Oh U, Woolbright E, Lehner-Gulotta D, Coleman R, Conaway M, Goldman MD, Brenton JN. Serum neurofilament light chain in relapsing multiple sclerosis patients on a ketogenic diet. Mult Scler Relat Disord. 2023;73:104670.
</cite> [<a href="https://doi.org/10.1016/j.msard.2023.104670" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10239314/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36996634/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Oh%20U,%20Woolbright%20E,%20Lehner-Gulotta%20D,%20Coleman%20R,%20Conaway%20M,%20Goldman%20MD,%20Brenton%20JN.%20Serum%20neurofilament%20light%20chain%20in%20relapsing%20multiple%20sclerosis%20patients%20on%20a%20ketogenic%20diet.%20Mult%20Scler%20Relat%20Disord.%202023;73:104670." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR40">
<span class="label">40.</span><cite>Silveira C, Guedes R, Maia D, Curral R, Coelho R. Neuropsychiatric symptoms of multiple sclerosis: state of the Art. Psychiatry Investig. 2019;16(12):877–88.
</cite> [<a href="https://doi.org/10.30773/pi.2019.0106" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6933139/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31805761/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Silveira%20C,%20Guedes%20R,%20Maia%20D,%20Curral%20R,%20Coelho%20R.%20Neuropsychiatric%20symptoms%20of%20multiple%20sclerosis:%20state%20of%20the%20Art.%20Psychiatry%20Investig.%202019;16(12):877%E2%80%9388." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR41">
<span class="label">41.</span><cite>Lee JE, Titcomb TJ, Bisht B, Rubenstein LM, Louison R, Wahls TL. A modified MCT-Based ketogenic diet increases plasma beta-Hydroxybutyrate but has less effect on fatigue and quality of life in people with multiple sclerosis compared to a modified paleolithic diet: A Waitlist-Controlled, randomized pilot study. J Am Coll Nutr. 2020;40:1–13.</cite> [<a href="https://doi.org/10.1080/07315724.2020.1734988" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11833548/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32213121/" class="usa-link">PubMed</a>]</li>
<li id="CR42">
<span class="label">42.</span><cite>Benedict RH, Cohan S, Lynch SG, Riester K, Wang P, Castro-Borrero W, Elkins J, Sabatella G. Improved cognitive outcomes in patients with relapsing-remitting multiple sclerosis treated with daclizumab beta: results from the DECIDE study. Mult Scler. 2018;24(6):795–804.
</cite> [<a href="https://doi.org/10.1177/1352458517707345" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5971365/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28485186/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Benedict%20RH,%20Cohan%20S,%20Lynch%20SG,%20Riester%20K,%20Wang%20P,%20Castro-Borrero%20W,%20Elkins%20J,%20Sabatella%20G.%20Improved%20cognitive%20outcomes%20in%20patients%20with%20relapsing-remitting%20multiple%20sclerosis%20treated%20with%20daclizumab%20beta:%20results%20from%20the%20DECIDE%20study.%20Mult%20Scler.%202018;24(6):795%E2%80%93804." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR43">
<span class="label">43.</span><cite>Button KS, Kounali D, Thomas L, Wiles NJ, Peters TJ, Welton NJ, Ades AE, Lewis G. Minimal clinically important difference on the Beck depression Inventory–II according to the patient’s perspective. Psychol Med. 2015;45(15):3269–79.
</cite> [<a href="https://doi.org/10.1017/S0033291715001270" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4611356/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26165748/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Button%20KS,%20Kounali%20D,%20Thomas%20L,%20Wiles%20NJ,%20Peters%20TJ,%20Welton%20NJ,%20Ades%20AE,%20Lewis%20G.%20Minimal%20clinically%20important%20difference%20on%20the%20Beck%20depression%20Inventory%E2%80%93II%20according%20to%20the%20patient%E2%80%99s%20perspective.%20Psychol%20Med.%202015;45(15):3269%E2%80%9379." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR44">
<span class="label">44.</span><cite>Fond G, Macgregor A, Leboyer M, Michalsen A. Fasting in mood disorders: neurobiology and effectiveness. A review of the literature. Psychiatry Res. 2013;209(3):253–8.
</cite> [<a href="https://doi.org/10.1016/j.psychres.2012.12.018" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23332541/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fond%20G,%20Macgregor%20A,%20Leboyer%20M,%20Michalsen%20A.%20Fasting%20in%20mood%20disorders:%20neurobiology%20and%20effectiveness.%20A%20review%20of%20the%20literature.%20Psychiatry%20Res.%202013;209(3):253%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR45">
<span class="label">45.</span><cite>Gibson AA, Seimon RV, Lee CM, Ayre J, Franklin J, Markovic TP, Caterson ID, Sainsbury A. Do ketogenic diets really suppress appetite? A systematic review and meta-analysis. Obes Rev. 2015;16(1):64–76.
</cite> [<a href="https://doi.org/10.1111/obr.12230" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25402637/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gibson%20AA,%20Seimon%20RV,%20Lee%20CM,%20Ayre%20J,%20Franklin%20J,%20Markovic%20TP,%20Caterson%20ID,%20Sainsbury%20A.%20Do%20ketogenic%20diets%20really%20suppress%20appetite?%20A%20systematic%20review%20and%20meta-analysis.%20Obes%20Rev.%202015;16(1):64%E2%80%9376." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR46">
<span class="label">46.</span><cite>Michalsen A, Schlegel F, Rodenbeck A, Ludtke R, Huether G, Teschler H, Dobos GJ. Effects of short-term modified fasting on sleep patterns and daytime vigilance in non-obese subjects: results of a pilot study. Ann Nutr Metab. 2003;47(5):194–200.
</cite> [<a href="https://doi.org/10.1159/000070485" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12748412/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Michalsen%20A,%20Schlegel%20F,%20Rodenbeck%20A,%20Ludtke%20R,%20Huether%20G,%20Teschler%20H,%20Dobos%20GJ.%20Effects%20of%20short-term%20modified%20fasting%20on%20sleep%20patterns%20and%20daytime%20vigilance%20in%20non-obese%20subjects:%20results%20of%20a%20pilot%20study.%20Ann%20Nutr%20Metab.%202003;47(5):194%E2%80%93200." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR47">
<span class="label">47.</span><cite>Górska E, Tylicka M, Hermanowicz A, Matuszczak E, Sankiewicz A, Gorodkiewicz E, Hermanowicz J, Karpinska E, Socha K, Kochanowicz J, Jakoniuk M, Kaminska J, Homsak E, Koper-Lenkiewicz OM. UCHL1, besides leptin and fibronectin, also could be a sensitive marker of the relapsing-remitting type of multiple sclerosis. Sci Rep-Uk. 2023;13(1).</cite> [<a href="https://doi.org/10.1038/s41598-023-30237-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9974955/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36854961/" class="usa-link">PubMed</a>]</li>
<li id="CR48">
<span class="label">48.</span><cite>Moharami S, Nourazarian A, Nikanfar M, Laghousi D, Shademan B, Joodi Khanghah O, Khaki-Khatibi F. Investigation of serum levels of orexin-A, transforming growth factor beta, and leptin in patients with multiple sclerosis. J Clin Lab Anal. 2022;36(1):e24170.
</cite> [<a href="https://doi.org/10.1002/jcla.24170" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8761413/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34894407/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Moharami%20S,%20Nourazarian%20A,%20Nikanfar%20M,%20Laghousi%20D,%20Shademan%20B,%20Joodi%20Khanghah%20O,%20Khaki-Khatibi%20F.%20Investigation%20of%20serum%20levels%20of%20orexin-A,%20transforming%20growth%20factor%20beta,%20and%20leptin%20in%20patients%20with%20multiple%20sclerosis.%20J%20Clin%20Lab%20Anal.%202022;36(1):e24170." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR49">
<span class="label">49.</span><cite>Matarese G, Carrieri PB, La Cava A, Perna F, Sanna V, De Rosa V, Aufiero D, Fontana S, Zappacosta S. Leptin increase in multiple sclerosis associates with reduced number of CD4(+)CD25 + regulatory T cells. Proc Natl Acad Sci U S A. 2005;102(14):5150–5.
</cite> [<a href="https://doi.org/10.1073/pnas.0408995102" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC555982/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15788534/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Matarese%20G,%20Carrieri%20PB,%20La%20Cava%20A,%20Perna%20F,%20Sanna%20V,%20De%20Rosa%20V,%20Aufiero%20D,%20Fontana%20S,%20Zappacosta%20S.%20Leptin%20increase%20in%20multiple%20sclerosis%20associates%20with%20reduced%20number%20of%20CD4(+)CD25%E2%80%89+%E2%80%89regulatory%20T%20cells.%20Proc%20Natl%20Acad%20Sci%20U%20S%20A.%202005;102(14):5150%E2%80%935." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR50">
<span class="label">50.</span><cite>Loonstra FC, Falize KF, de Ruiter LRJ, Schoonheim MM, Strijbis EMM, Killestein J, de Vries HE, Uitdehaag BMJ, Rijnsburger M. Adipokines in multiple sclerosis patients are related to clinical and radiological measures. J Neurol. 2023;270(4):2018–30.
</cite> [<a href="https://doi.org/10.1007/s00415-022-11519-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10025234/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36562851/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Loonstra%20FC,%20Falize%20KF,%20de%20Ruiter%20LRJ,%20Schoonheim%20MM,%20Strijbis%20EMM,%20Killestein%20J,%20de%20Vries%20HE,%20Uitdehaag%20BMJ,%20Rijnsburger%20M.%20Adipokines%20in%20multiple%20sclerosis%20patients%20are%20related%20to%20clinical%20and%20radiological%20measures.%20J%20Neurol.%202023;270(4):2018%E2%80%9330." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR51">
<span class="label">51.</span><cite>Igwe O, Sone M, Matveychuk D, Baker GB, Dursun SM. A review of effects of calorie restriction and fasting with potential relevance to depression. Prog Neuropsychopharmacol Biol Psychiatry. 2021;111:110206.
</cite> [<a href="https://doi.org/10.1016/j.pnpbp.2020.110206" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33316333/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Igwe%20O,%20Sone%20M,%20Matveychuk%20D,%20Baker%20GB,%20Dursun%20SM.%20A%20review%20of%20effects%20of%20calorie%20restriction%20and%20fasting%20with%20potential%20relevance%20to%20depression.%20Prog%20Neuropsychopharmacol%20Biol%20Psychiatry.%202021;111:110206." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR52">
<span class="label">52.</span><cite>Siddiqui K, Browne RW, Benedict RHB, Jakimovski D, Weinstock-Guttman B, Zivadinov R, Ramanathan M. Cholesterol pathway biomarkers are associated with neuropsychological measures in multiple sclerosis. Mult Scler Relat Disord. 2023;69:104374.
</cite> [<a href="https://doi.org/10.1016/j.msard.2022.104374" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36403378/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Siddiqui%20K,%20Browne%20RW,%20Benedict%20RHB,%20Jakimovski%20D,%20Weinstock-Guttman%20B,%20Zivadinov%20R,%20Ramanathan%20M.%20Cholesterol%20pathway%20biomarkers%20are%20associated%20with%20neuropsychological%20measures%20in%20multiple%20sclerosis.%20Mult%20Scler%20Relat%20Disord.%202023;69:104374." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR53">
<span class="label">53.</span><cite>Andaloro A, Russo M, Pastura C, Sessa E, Calatozzo P, Maggio MG, Bramanti P. Is there a correlation between dyslipidemia and cognitive impairment in patients with multiple sclerosis? Int J Neurosci. 2020;132.</cite> [<a href="https://doi.org/10.1080/00207454.2020.1807980" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32767908/" class="usa-link">PubMed</a>]</li>
<li id="CR54">
<span class="label">54.</span><cite>Noori H, Gheini MR, Rezaeimanesh N, Saeedi R, Aliabadi HR, Sahraian MA, Moghadasi AN. The correlation between dyslipidemia and cognitive impairment in multiple sclerosis patients. Mult Scler Relat Dis. 2019;36.</cite> [<a href="https://doi.org/10.1016/j.msard.2019.101415" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31586799/" class="usa-link">PubMed</a>]</li>
<li id="CR55">
<span class="label">55.</span><cite>Hernandez-Ledesma AL, Rodriguez-Mendez AJ, Gallardo-Vidal LS, Garcia-Gasca T, Alatorre-Cruz JM, Garcia-Solis P, Lopez Reyes J, Solis-Sainz JC. Lipid profile: causal relationship on cognitive performance in multiple sclerosis? Mol Biol Rep. 2020;47(12):9667–76.
</cite> [<a href="https://doi.org/10.1007/s11033-020-06011-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33259011/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hernandez-Ledesma%20AL,%20Rodriguez-Mendez%20AJ,%20Gallardo-Vidal%20LS,%20Garcia-Gasca%20T,%20Alatorre-Cruz%20JM,%20Garcia-Solis%20P,%20Lopez%20Reyes%20J,%20Solis-Sainz%20JC.%20Lipid%20profile:%20causal%20relationship%20on%20cognitive%20performance%20in%20multiple%20sclerosis?%20Mol%20Biol%20Rep.%202020;47(12):9667%E2%80%9376." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR56">
<span class="label">56.</span><cite>Silva AS, Guimaraes J, Sousa C, Mendonca L, Soares-Dos-Reis R, Mendonca T, Abreu P, Sequeira L, Sa MJ. Metabolic syndrome parameters and multiple sclerosis disease outcomes: A Portuguese cross-sectional study. Mult Scler Relat Disord. 2023;69:104370.
</cite> [<a href="https://doi.org/10.1016/j.msard.2022.104370" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36401965/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Silva%20AS,%20Guimaraes%20J,%20Sousa%20C,%20Mendonca%20L,%20Soares-Dos-Reis%20R,%20Mendonca%20T,%20Abreu%20P,%20Sequeira%20L,%20Sa%20MJ.%20Metabolic%20syndrome%20parameters%20and%20multiple%20sclerosis%20disease%20outcomes:%20A%20Portuguese%20cross-sectional%20study.%20Mult%20Scler%20Relat%20Disord.%202023;69:104370." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR57">
<span class="label">57.</span><cite>Oliveira SR, Simao AN, Kallaur AP, de Almeida ER, Morimoto HK, Lopes J, Dichi I, Kaimen-Maciel DR, Reiche EM. Disability in patients with multiple sclerosis: influence of insulin resistance, adiposity, and oxidative stress. Nutrition. 2014;30(3):268–73.
</cite> [<a href="https://doi.org/10.1016/j.nut.2013.08.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24484677/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Oliveira%20SR,%20Simao%20AN,%20Kallaur%20AP,%20de%20Almeida%20ER,%20Morimoto%20HK,%20Lopes%20J,%20Dichi%20I,%20Kaimen-Maciel%20DR,%20Reiche%20EM.%20Disability%20in%20patients%20with%20multiple%20sclerosis:%20influence%20of%20insulin%20resistance,%20adiposity,%20and%20oxidative%20stress.%20Nutrition.%202014;30(3):268%E2%80%9373." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR58">
<span class="label">58.</span><cite>Penesova A, Vlcek M, Imrich R, Vernerova L, Marko A, Meskova M, Grunnerova L, Turcani P, Jezova D, Kollar B. Hyperinsulinemia in newly diagnosed patients with multiple sclerosis. Metab Brain Dis. 2015;30(4):895–901.
</cite> [<a href="https://doi.org/10.1007/s11011-015-9665-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25809135/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Penesova%20A,%20Vlcek%20M,%20Imrich%20R,%20Vernerova%20L,%20Marko%20A,%20Meskova%20M,%20Grunnerova%20L,%20Turcani%20P,%20Jezova%20D,%20Kollar%20B.%20Hyperinsulinemia%20in%20newly%20diagnosed%20patients%20with%20multiple%20sclerosis.%20Metab%20Brain%20Dis.%202015;30(4):895%E2%80%93901." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR59">
<span class="label">59.</span><cite>Zhornitsky S, McKay KA, Metz LM, Teunissen CE, Rangachari M. Cholesterol and markers of cholesterol turnover in multiple sclerosis: relationship with disease outcomes. Mult Scler Relat Disord. 2016;5:53–65.
</cite> [<a href="https://doi.org/10.1016/j.msard.2015.10.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26856944/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhornitsky%20S,%20McKay%20KA,%20Metz%20LM,%20Teunissen%20CE,%20Rangachari%20M.%20Cholesterol%20and%20markers%20of%20cholesterol%20turnover%20in%20multiple%20sclerosis:%20relationship%20with%20disease%20outcomes.%20Mult%20Scler%20Relat%20Disord.%202016;5:53%E2%80%9365." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR60">
<span class="label">60.</span><cite>Dossi DE, Chaves H, Heck ES, Rodriguez Murua S, Ventrice F, Bakshi R, Quintana FJ, Correale J, Farez MF. Effects of systolic blood pressure on brain integrity in multiple sclerosis. Front Neurol. 2018;9:487.
</cite> [<a href="https://doi.org/10.3389/fneur.2018.00487" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6026666/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29988562/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Dossi%20DE,%20Chaves%20H,%20Heck%20ES,%20Rodriguez%20Murua%20S,%20Ventrice%20F,%20Bakshi%20R,%20Quintana%20FJ,%20Correale%20J,%20Farez%20MF.%20Effects%20of%20systolic%20blood%20pressure%20on%20brain%20integrity%20in%20multiple%20sclerosis.%20Front%20Neurol.%202018;9:487." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR61">
<span class="label">61.</span><cite>Motl RW, Baird JF, Sandroff BM, Baynard T, Fernhall B. Blood pressure and cognition in older adults with multiple sclerosis: preliminary examination. Neurol Sci. 2023;44(2):677–83.
</cite> [<a href="https://doi.org/10.1007/s10072-022-06466-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36287283/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Motl%20RW,%20Baird%20JF,%20Sandroff%20BM,%20Baynard%20T,%20Fernhall%20B.%20Blood%20pressure%20and%20cognition%20in%20older%20adults%20with%20multiple%20sclerosis:%20preliminary%20examination.%20Neurol%20Sci.%202023;44(2):677%E2%80%9383." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR62">
<span class="label">62.</span><cite>Marrie RA, Patel R, Figley CR, Kornelsen J, Bolton JM, Graff LA, Mazerolle EL, Helmick C, Uddin MN, Figley TD, Marriott JJ, Bernstein CN, Fisk JD. Effects of vascular comorbidity on cognition in multiple sclerosis are partially mediated by changes in brain structure. Front Neurol. 2022;13:910014.
</cite> [<a href="https://doi.org/10.3389/fneur.2022.910014" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9170886/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35685743/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Marrie%20RA,%20Patel%20R,%20Figley%20CR,%20Kornelsen%20J,%20Bolton%20JM,%20Graff%20LA,%20Mazerolle%20EL,%20Helmick%20C,%20Uddin%20MN,%20Figley%20TD,%20Marriott%20JJ,%20Bernstein%20CN,%20Fisk%20JD.%20Effects%20of%20vascular%20comorbidity%20on%20cognition%20in%20multiple%20sclerosis%20are%20partially%20mediated%20by%20changes%20in%20brain%20structure.%20Front%20Neurol.%202022;13:910014." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR63">
<span class="label">63.</span><cite>Roman SN, Fitzgerald KC, Beier M, Mowry EM. Safety and feasibility of various fasting -mimicking diets among people with multiple sclerosis. Mult Scler Relat Dis. 2020;42.</cite> [<a href="https://doi.org/10.1016/j.msard.2020.102149" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32408153/" class="usa-link">PubMed</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12366206/bin/40795_2025_1156_MOESM1_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">40795_2025_1156_MOESM1_ESM.docx</a><sup> (114.9KB, docx) </sup><p><strong>Supplementary Material 1</strong>: <strong>Suppl. Table 1</strong>. Adverse events in the Intention-to-Treat population of the NAMS study. <strong>Suppl. Table 2.</strong> Serious adverse events in the Intention-to-Treat population of the NAMS study. <strong>Suppl. Table 3.</strong> Outcome data of the NAMS study at baseline in the Full Analysis Set (FAS). <strong>Suppl. Table 4.</strong> Outcome data of the NAMS at 9 months in the Full Analysis Set (FAS). <strong>Suppl. Table 5.</strong> Outcome data of the NAMS at 18 months in the Full Analysis Set (FAS). <strong>Suppl. Table 6.</strong> Dietary intake data for all participants. <strong>Suppl. Table 7.</strong> Dietary intake data for standard diet group. <strong>Suppl. Table 8.</strong> Dietary intake data for fasting diet group. <strong>Suppl. Table 9.</strong> Dietary intake data for ketogenic diet group. <strong>Suppl. Table 10.</strong> CONSERVE Checklist.</p>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material2_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12366206/bin/40795_2025_1156_MOESM2_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 2</a><sup> (20.4KB, docx) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The datasets used and analysed during the current study available from the corresponding author on reasonable request. Requests can be directed to lina.bahr@charite.de.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from BMC Nutrition are provided here courtesy of <strong>BMC</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1186/s40795-025-01156-5"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/40795_2025_Article_1156.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (3.3 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12366206/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12366206/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12366206%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12366206/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12366206/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12366206/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40836308/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12366206/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40836308/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12366206/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12366206/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="zCrQT8kmvVgHQIf3zlpPAefxb0poNetfSzrzBe92QsYWpdAe8U9Wgei8ZQaXan2n">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
